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ABSTRACT OF DISSERTATION 
 
 
CHARACTERIZATION OF JABBA, A RICIN-RESISTANT MUTANT OF 
LEISHMANIA DONOVANI 
The abundant cell-surface lipophosphoglycan (LPG) of Leishmania parasites 
plays a central role throughout the eukaryote’s life cycle.  A number of LPG-defective 
mutants and their complementing genes have been isolated and have proven invaluable in 
assessing the importance of LPG and related glycoconjugates in parasite virulence. While 
ricin agglutination selection protocols frequently result in lpg- mutants, one L. donovani 
variant we isolated, named JABBA, was found to be lpg+.  Procyclic (logarithmic) 
JABBA expresses significant amounts of a large-sized LPG, larger than observed from 
procyclic wild-type but similar in size to LPG from wild-type from metacyclic 
(stationary) phase.  
 
 Structural analysis of the LPG from logarithmically-grown JABBA by capillary 
electrophoresis protocols revealed that it averaged 30 repeat units composed of the 
unsubstituted Gal(β1,4)Man(α1)-PO4 typical of wild-type L. donovani.  Analysis of 
JABBA LPG caps indicated that 20% are the disaccharide Glc(β1,2)Man, trisaccharide 
Gal(β1,4)[Glc(β1,2)]Man, and tetrasaccharide Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man in 
addition to wild-type Gal(β1,4)Man and Man(α1,2)Man and Gal(β1,4)[Man(α1,2)]Man 
terminating caps, These glucose containing isoforms were absent in stationary parasites.  
 
Consistent with these structural observations, analyses of the relevant 
glycosyltransferases in JABBA microsomes involved in LPG biosynthesis showed a two-
fold increase in elongating mannosylphosphoryltransferase activity and up-regulation of a 
β-glucosyltransferase activity. The β-glucosyltransferase in both JABBA and wild-type 
in vitro produced a β-glucosidase sensitive and β-galactosidase sensitive trisaccharide, 
indicative of the mannose of repeating units and caps being used in substrate, novel in 
comparison to other Leishmania species.  Furthermore, the caps of JABBA LPG are 
cryptic in presentation as shown by the loss of binding by the lectins ricin, peanut 
agglutinin and concanavalin A and reduced accessibility of the terminal galactose 
residues to oxidation by galactose oxidase.   
 
 
These results indicate that LPG from JABBA is intriguingly similar to the larger 
LPG in wild-type parasites that arises following the differentiation of the non-infectious 
procyclic promastigotes to infectious, metacyclic forms, and has a unique β-
glucosyltransferase not active in vivo in wild-type parasites.  
 
KEYWORDS: Parasites, Glycosyltransferases, Ricin Agglutinin, Leishmania, 
 Lipophosphoglycan.  
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Chapter I 
Introduction 
 
 The World Health Organization lists leishmaniasis as one of its top six tropical 
diseases for research and control efforts. Approximately 350 million people (Kaye, P. and 
Scott, P. 2011) in 88 countries are at risk, with 1-2 million new cases a year, making 
leishmaniasis the second most common parasitic disease in the world behind malaria. 
There are three primary forms of leishmaniasis, which range from self-healing ulcers to 
disfiguring or deadly infections. The host’s immune system and the species of parasite 
have been shown to cause the varying state of illness. Drug treatments are few, most are 
toxic, and resistance to those drugs is showing up in areas where leishmaniasis is 
endemic. Vaccination development is slow, and the focus has been on vaccination of 
non-human reservoirs.  
 Leishmania parasites lead a complex life cycle, and have a complex glycocalyx to 
protect them. They have two forms in this cycle, the promastigote, and an amastigote. 
The promastigote is ingested by a sand fly when it consumes a blood meal from an 
infected mammal, it will then reside in the sand fly’s midgut for approximately a week, 
undergoing metacyclogenesis to become the infectious parasite. When the parasites 
release from the midgut they migrate to the mouth parts to be injected at the next blood 
meal. In the newly infected mammal, the parasites travel to the macrophage, where they 
reside in the phagolysosome change into amastigotes, the form during the course of 
infection. 
 In order to survive the sand fly midgut, the mammalian bloodstream, and the 
mammalian macrophage, Leishmania have an extensive glycocalyx containing a variety 
of glycolipids, GPI-anchored proteins, and secreted glycoproteins. Lipophosphoglycan 
(LPG) is the dominant molecule coating the surface of promastigotes, found in excess of 
one million copies. The basic structure of LPG is a conserved glycan core and a 
phospholipid anchor, a developmentally regulated number of disaccharide repeating 
units, and a neutral oligosaccharide cap. LPG plays a role in midgut attachment, parasite 
virulence, and host immune response. 
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Current research in this lab has focused on identifying critical molecules in the 
LPG biosynthesis pathway. The unique structures found on LPG have made it a potential 
drug target with potentially fewer toxic side effects compared to most anti-protozoal 
drugs. Parasites were exposed to mutagens in order to generate a selection of mutant 
strains, and parasites with abnormal LPG structures were selected for further study. This 
dissertation introduces JABBA, the first over-expressing LPG mutant, and analyzes the 
structure of its mutant LPG and the biochemical causes for the changes. Lastly, we utilize 
lectins to determine how the altered LPG structure could affect the parasites life cycle.  
1. Leishmaniasis
Leishmaniasis is caused by multiple species, found in multiple countries, and 
presents a variety of clinical manifestations. Cutaneous leishmaniasis is found 
predominantly in Africa, the Mediterranean, the Middle East, and Asia and parts of India. 
The species that cause the bulk of cutaneous leishmaniasis are L. major, L. tropica, L. 
mexicana (western hemisphere), and L. aethiopica (Berman, J.D. 1997;Grimaldi, G., Jr., 
et al. 1989). The disease can develop within a few days or over years after the bite from 
an infected sand fly, presenting with a lesion that is covered by a thin crust and slowly 
spreads. These sores can heal on their own leaving unpigmented scars. A secondary case 
can occur called diffuse cutaneous leishmaniasis, causing nodules and plaques to form 
under the skin of extremities months or years after the initial infection. Another unique 
form of cutaneous leishmaniasis is mucocutaneous leishmaniasis (Berman, J.D. 1997), 
localized from Mexico to Argentina, and caused by L. braziliensis and L. panemaensis. 
After an initial cutaneous infection has ran its course, the parasites metastasize to the 
mucus membranes, forming ulcers which destroy the mucus membranes of the nose and 
mouth.  
Visceral leishmaniasis, or “kala azar” in India, is found in the Mediterranean, 
Russia, China, India, and East Africa and caused by parasites of the L. donovani 
complex. In the western hemisphere, the disease is caused by L. tropica, L. amazonesis, 
and L. chagasi (Berman, J.D. 1997;Grimaldi, G., Jr., et al. 1989). Symptoms include 
fever, weight-loss, anemia, and swelling of the spleen and liver; untreated, mortality is 
guaranteed. As with cutaneous leishmaniasis, the incubation period is a few days to a 
3 
year after bite from infected sand fly. Currently, co-infection with HIV has become a 
major concern with visceral leishmaniasis (Montalban, C. 1991). 
The best treatment option available currently is miltefosine, a drug given orally, 
rather than intravenously (Coelho, A.C., et al. 2014). Miltefosine is a derivative of 
phosphadtidylcholine, and was approved by the FDA for the treatment of all 
leishmaniases in 2014. However, during 2013, in Asia Minor and India approximately 
20% of patients given miltefosine relapsed within a year (Vanaerschot, M., et al. 
2014a;Vanaerschot, M., et al. 2014b) 
Other treatments for leishmaniasis rely on pentavalent antimonial drugs which 
inhibit glycolytic enzymes and fatty acid oxidation in amastigotes (Markell, 1999). 
Sodium stibogluconate and N-methylgucamin antimonials require a 20 day course of 
medication (Berman, J.D. 1997;Grimaldi, G., Jr. and Tesh, R.B. 1993) but the side effects 
of these treatments require monitoring and in locations affected by leishmaniases the 
overall course is often not completed.  
Pentamidine and Amphotericin B are possible forms of treatment, with the latter 
proving extremely effective. Both of these drugs however are toxic to humans at the 
necessary therapeutic levels (Berman, J.D. 1997;Herwaldt, B.L., et al. 1992;Melby, P.C. 
2002), with side effects intense enough that patients must be medically monitored.  
Cutaneous leishmaniasis does not require treatment, and antibodies developed from 
untreated cutaneous leishmaniasis are effective against future cases in most people. 
Vaccinations against leishmaniasis have been proposed in a variety of forms. 
Recently a number have focused on different proteases in New World species 
(Zahedifard, F., et al. 2014), some that could even be administered intra-nasally (de 
Matos Guedes, H.L., et al. 2014). A uniform problem has been found in translating 
vaccine designs to humans, as most vaccines with favorable results in mice do not prove 
successful in humans (de Matos Guedes, H.L., et al. 2014). The newest technique 
attempts to use live attenuated parasites to produce an immune response, with moderate 
success (Dey, R., et al. 2014). The biggest leap forward overall in working to control 
leishmaniasis is the development of two commercially available vaccines for dogs 
(Fernandes, C.B., et al. 2014), a frequent mammalian host for the parasite.  
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2. Life Cycle 
 Leishmania sp. are members of the order Kinetoplastida, in the family 
Trypanosmatida. A number of infectious parasites reside in the same family, including 
the highly prevalent Chagas Disease. Characteristic of the Kinetoplastid family, the 
parasite has a kinetoplast, a single tubular mitochondrion of condensed DNA consisting 
of roughly 20,000 minicircles of DNA and 20-50 maxicircles, at the base of the 
flagellum. The parasites have a single nucleus and either an elongated body with a long 
protruding flagellum or a short body with a nonprotruding flagellum.  Leishmania and 
some other trypanosomes are heteroxenous, others, such as Herptomonas, are 
monoxenous. 
 Leishmania have a digenetic life cycle (Turco, S.J. and Descoteaux, A. 1992), a 
model of which is illustrated in Figure 1. Parasites are ingested by the sand fly during its 
blood meal, and they proceed to differentiate in the alimentary tract of the sand fly. In the 
midgut the parasites attach to the epithelium using insect lectins (Kamhawi, S., et al. 
2004;Sacks, D.L., et al. 1995), and over the course of approximately a week the parasites 
undergo metacyclogenesis and transition to the metacyclic promastigote (de Assis, R.R., 
et al. 2012;Sacks, D.L. 1989). While it has not been seen in the wild, co-infection of a 
sand fly can result in DNA exchange between species (Akopyants, N.S., et al. 
2009;Inbar, E., et al. 2013). Promastigotes, the life cycle form in the sand fly, are spindle 
shaped, 10-15 µM in length, and 2-3 µM in diameter with the flagellum at the basal body 
of the anterior pole and highly motile for its migration to the proboscis.. Approximately 
10 different forms have been described, varying by species and sand fly vector (Lawyer, 
P.G., et al. 1990).  
 A variety of systems are used to culture promastigotes. They grow as a 
heterogenous population in liquid culture, with population percentages varying based on 
culture conditions and growth phase. The parasites prefer temperatures about 24-26 ºC 
and a neutral to slightly acidic pH, similar to the conditions found in the sand fly midgut. 
The actual infectivity of a liquid culture varies, it is estimated that 10% of the stationary 
phase culture manages to fully differentiate into metacyclic parasites. Lectins are used to 
select for the unique cell surface antigens found on metacyclics, isolating that population 
for further study (Sacks, D.L. and da Silva, R.P. 1987;Sacks, D.L. and Perkins, P.V. 
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1985). For example, peanut agglutinin is used to identify metacyclic L. donovani 
parasites due to their resistance to agglutination.  Recently algorithms have been 
developed to identify metacyclic parasites based on the slight changes in cell architecture, 
including an extreme narrowing of the cell (Berg, M., et al. 2013).  
 In the mammalian host, the aflagellated amastigote develops in the 
parasitophorous vacuole contained in the macrophage (Turco, S.J. and Descoteaux, A. 
1992), where it continues to replicate until it lyses the macrophage and spills out to infect 
other cells. The amastigotes are round, approximately 2-3 µM in diameter and lack a 
visible flagellum, as it does not extend past the cell circumference. Amastigotes can be 
grown axenically (Bates, P.A., et al. 1988;Doyle, P.S., et al. 1991), a low pH and high 
temperature are required to trigger the transformation (Zilberstein, D. and Shapira, M. 
1994). 
 
3. Structure of Lipophosphoglycan 
 Leishmania parasites encounter a number of hostile environments between the 
sand fly and host, and thus require an extensive, dense, glycocalyx (seen in Figure 1.2) 
for survival and protection. The glycocalyx consists of lipophosphoglycan (LPG), 
glycoinositolphospholipids (GIPLs) (McConville, M.J. and Blackwell, J.M. 
1991;Orlandi, P.A., Jr. and Turco, S.J. 1987;Turco, S.J., et al. 1987), excreted 
proteophosphoglycans (PPG) (Ilg, T., et al. 1994a;Ilg, T., et al. 1996;Ilg, T., et al. 1994b) 
and secreted acid phosphatase (sAP) (Lovelace, J.K. and Gottlieb, M. 1986). LPG is one 
of the dominant molecules in the promastigote phase, found all over the cell surface 
including the flagellum with approximately one million copies per cell.  
 LPG consists of four domains: (i) a lipid anchor, (ii) glycan core, (iii) 
Gal(β1,4)Man(α1)-PO4 repeating units, and (iv) an oligosaccharide cap structure 
(Descoteaux, A. and Turco, S.J. 1999;Turco, S.J. and Descoteaux, A. 1992). The lipid is 
a 1-O-alkyl-2-lyso-phospatidyl(myo)inositol, containing an aliphatic C24 or C26 
unbranched, saturated hydrocarbon. The glycan core contains an unacylated glucosamine, 
2 mannopyranoses, 2 galactopyranoses, and a unique galactofuranose residue. L. 
donovani and L. mexicana contain a Glc(α1)-PO4 attached to the C-6 hydroxyl of the 
proximal mannose via a phosphodiester bond (Ilg, T., et al. 1992;Turco, S.J., et al. 1989).  
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 The core, lipid, and repeating unit backbone are highly conserved among species, 
while the distinguishing variations between species are found in the side chains attached 
to the repeating units and the caps (Figure 1.3), with the C-3 of the galactosyl residue the 
most common location for modifications. L. donovani isolated from Sudan contains no 
side-chain modifications (Turco, S.J., et al. 1987), while the Indian isolate contains one 
or two β-glucosyl residues linked every few repeating units (Mahoney, A.B., et al. 1999). 
L. major contains 1-4 β-galactosyl chains terminated with arabinosyl  (Dobson, D.E., et 
al. 2003b;Sacks, D.L., et al. 1990), L. mexicana contains β-glucosyl chains, and L. 
tropica is the most complex with over 19 different types of glycans (Soares, R.P., et al. 
2004). L. aethopica is the only LPG found that contains α-mannosyl side chains linked to 
the C-2 of the mannosyl residue (McConville, M.J., et al. 1995). The caps are frequently 
varied, the common structure found in L. donovani is the trisaccharide 
Gal(β1,4)[Manα1,2]Man, and L. major has a dominant Man(α1,2)Man cap.  
 LPG is the primary ligand for binding to the midgut epithelium of the sand fly. 
The developmentally regulated changes are known to help in both attachment and 
eventual detachment from the midgut. This includes an increase in repeating units from 
approximately 15 to 30 as the parasite undergoes metacyclogenesis and potentially 
changes in side chains, in the case of L. major, there is a downregulation in the number of 
galactosyl side chains and capped with an arabinosyl residue. This, along with the 
changes in the number of repeating units, helps facilitate its release from the sand fly gut 
(Pimenta, P.F., et al. 1992;Volf, P., et al. 2014). L. donovani uses the increase in 
repeating units alone, and this increase has been shown to hide the terminal cap from 
lectin accessibility in vitro (Sacks, D.L., et al. 1995).  
 LPG molecules are still expressed in the amastigote stage, but are extremely 
downregulated, with no more than 1000 molecules per cell (Schneider, P., et al. 1993). In 
L. major, these LPG molecules are biochemically distinct from the promastigote stage, 
including about 36 repeating units, with 70% of them unsubstituted. The substitutions 
include either glucosyl or galactosyl chains, with a maximum of 11 residues attached to a 
repeating unit and a predominantly Gal(β1,4)Man cap (Moody, S.F., et al. 1993).  
 There are some excreted molecules of LPG (Slutzky, G.M., et al. 1979)both with 
and without the lipid anchor. Those without the lipid are called phosphoglycans (Greis, 
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K.D., et al. 1992). While the reason for this variation is not quite understood, those with 
the lipid are thought to arise through the interaction of albumin in the media with LPG on 
the cell surface causing this turnover. 
4. Other Cell Surface Glycoconjugates
Leishmania produce a number of other glycoconjugates which will be discussed 
here. 
A. Glycoinositolphospholipids 
Glycoinsoitolphospholipids (GIPLs) are low molecular weight glycolipids that are 
expressed on the cell surface; they can resemble protein anchors, but do not explicitly 
anchor proteins (McConville, M.J., et al. 1993;McConville, M.J., et al. 1994;Turco, S., et 
al. 1994). They are expressed in extremely high copy number, and have three basic types: 
Type 1 resembles protein GPI anchors, Type 2 resembles those of LPG glycan core, and 
a third type that is expressed as a hybrid of the two.  Type I and the hybrid differ in the 
lipid composition, as they contain an alkyl-acyl-PI with shorter chains than LPG, while 
Type 2 produce a heterogeneous mixture. Little is known about the functions of GIPLs, 
but they are a major constituent of the amastigote cell surface, likely conferring 
protection to some capacity. They have been demonstrated to modulate signal events in 
the macrophage such as nitric oxide synthesis and the oxidative burst(McNeely, T.B., et 
al. 1989;Proudfoot, L., et al. 1995b),(Schofield, L., et al. 1996;Tachado, S.D., et al. 
1997). The enzymes in GPIL biosynthesis have been demonstrated to be essential for 
virulence (Ilgoutz, S.C., et al. 1999) 
B. gp63 
With approximately 500,000 copies per cell, gp63 is the major protein found on 
the surface of promastigote parasites, where it makes up a total of 1% of all cellular 
protein. The production of gp63 is downregulated in the amastigote stage of the life cycle 
and is found only in the flagellar pocket.  
The importance of the molecule is not well understood. It is seen to be 
proteolytically active against a number of molecules (Schlagenhauf, E., et al. 1998), and 
is considered a possible ligand for complement components. The high-mannose 
oligosaccharides found on its surface could be used for cell invasion using the mannose-
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fucose receptor. Overall, there is conflicting data as L. mexicana lacking gp63 suffers no 
apparent detriment in macrophages or in a mouse model of infection (Hilley, J.D., et al. 
2000). 
C. Secreted acid phosphatase 
All promastigotes, save L. major, release secreted acid phosphatase (sAP) from 
the flagellar pocket (Bates, P.A., et al. 1989;Lovelace, J.K. and Gottlieb, M. 
1987;Stierhof, Y.D., et al. 1994) and can be found in cellular media. Old World strains of 
Leishmania, including L. donovani, release mono or oligomeric sAPs, while New World 
strains release a filamentous sAP (Ilg, T., et al. 1999;Ilg, T., et al. 1994a). L. donovani 
sAPs are heavily glycosylated on the C-terminal serine or threonine domains via 
phosphodiester linkages, and have about 32 Gal(β1,4)Man(α1)-PO4 repeating units. In 
contrast, L. mexicana is oligomannosylated. 
D. Proteophosphoglycan 
There are a number of types of proteophosphoglycan (PPG): filamentous PPG 
(fPPG), GPI-anchored form (mPPG), and an amastigote, non-filamentous form (aPPG) 
(Ilg, T., et al. 1994b;Stierhof, Y.D., et al. 1994). fPPG is 95% phosphoglycans, while the 
protein component is primarily serine, alanine, and proline. The serine molecules are 
phosphoglycosylated with the repeating units Gal(β1,4)Man(α1)-PO4 terminated with 
small cap structures. There is no obvious evidence for its function, but hypotheses 
suggest that it traps the parasites in the midgut or deters the ingestion of a second blood 
meal (Killick-Kendrick, R., et al. 1988). 
aPPG has a defined polypeptide backbone with modified phosphoglycans, both 
common and novel structures, present on the serine residues (Ilg, T., et al. 1998). In the 
parasitophorous vacuole, the concentrations of aPPG can be as high as mgs/ml (Ilg, T., et 
al. 1995) and contributes to the overall size of the vacuole. These have been shown to 
activate the complement cascade. 
5. Functions of LPG
A. In the sand fly vector 
Leishmania species use the sand flies of two primary genera and many species as 
its vector. Old world strains of Leishmania use Phlebotomus spp. and New World strains 
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use Lutzomyia. As of this writing, two different capabilities of binding (LPG dependent 
and LPG independent) have been established, non-permissive and permissive vectors 
(Jecna, L., et al. 2013). In the case of L. major, the primary vector is P. papatsi, and is 
referred to as the non-permissive vector; P. perniciosus is the permissive vector.  
Using L. major mutants lacking LPG it has recently been shown that the non-
permissive, or primary, vector has an explicitly LPG dependent mechanism of binding to 
the mid-gut epithelium. This had been demonstrated in other capacities over the years 
using purified LPGs (Butcher, B.A., et al. 1996;Pimenta, P.F., et al. 1992). At the same 
time, a non-permissive species binding has been established that exhibits a non-LPG 
dependent mechanism for binding to the midgut. Parasite attachment is critical as it 
allows the parasite to undergo the life cycle progression of metacyclogenesis without 
being excreted (Sacks, D.L. and Perkins, P.V. 1984;Sacks, D.L. and Perkins, P.V. 1985). 
 The lengthening of LPG from 15 repeating units to 30 repeating units results in 
detachment from the epithelium (Sacks, D.L., et al. 1995). Data has shown that in L. 
major and nonpermissive binding, in addition to the increase in repeating units, the 
capping of β-galactosyl chains with an arabinosyl residues obscures the motif from the 
insect lectins to aid in detachment. In L. donovani (Sudanese isolate) the caps lose 
accessibility to lectins, which most likely allows for the detachment from the midgut and 
migration to the mouth parts. The L. donovani (Indian isolate) has been shown to rely on 
the glucose side chains in vitro for the binding of the parasite to the insect midgut, and 
that the decrease in glucose as it progresses through metacyclogenesis aids in detachment 
(Mahoney, A.B., et al. 1999). The three dimensional structure of LPG is critical to the 
parasite’s attachment in the sand fly and subsequent release for the continuation of its life 
cycle.  
B. In the mammalian bloodstream 
 Leishmania parasites must use the host immune cells to gain access to the 
macrophage which is normally used to eliminate pathogens. Upon initial infection in the 
bloodstream, the promastigotes are exposed to complement mediated lysis by 
complement factors. Logarithmic phase procyclic promastigotes are sensitive to fresh 
blood serum and lysis, while stationary phase promastigotes are increasingly resistant to 
lysis (Franke, E.D., et al. 1985;Puentes, S.M., et al. 1988). When compared to 
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logarithmic-phase L. major, peanut agglutinin purified metacyclics show that 
complement lysis does not affect binding.   
Metacyclic parasites manage to activate the complement cascade via the classical 
pathway, as C3b is bound on the surface. The membrane attack complex of traditional 
cascade occurs by cleavage of the factors.  L. major cannot have C5b-9 inserted on its 
surface, essentially forming a protective barrier (Puentes, S.M., et al. 1990;Puentes, S.M., 
et al. 1989;Puentes, S.M., et al. 1988). In the case of L. donovani (Sudanese isolate), only 
inactive C3b is bound to LPG, which does not result in activation of the C5 convertase 
(Puentes, S.M., Dwyer, D.M., et al. 1989), which will later help with a neutral 
phagocytosis by the macrophage. Bound C3 can then be released by proteolytic cleavage. 
Gp63 can cleave active C3b to its inactive form. In addition to complement, mannan-
binding protein can bind to the caps and trigger the complement cascade (Descoteaux, A. 
and Turco, S.J. 1999). 
C. In the mammalian macrophage 
 LPG and gp63 are the primary parasite receptors for binding to the macrophage; 
CR1, CR3, and the mannose-fucose receptor are the primary receptors for the 
macrophage. Inactive C3b allows for opsonization through CR1 and CR3 (Mosser, D.M. 
and Edelson, P.J. 1985), though L. donovani can bind in the absence of these  through the 
mannose-fucose receptor with a mannose-terminating cap (Mosser, D.M., et al. 1992). 
Binding through CR3 triggers phagocytosis without the oxidative burst (Wright, S.D. and 
Silverstein, S.C. 1983) allowing for easy entry into the macrophage while also inhibiting 
IL-12 induced cell-mediated immunity (Descoteaux, A. and Turco, S.J. 1999). The 
multiple ways Leishmania parasites can enter immune cells allows for initial entry to 
Langerhans cells in the skin, where inducible nitric oxide synthase allows for the parasite 
to outwit the immune system (Alexander, J., et al. 1999). 
 After endocytosis the parasite enters a phagosome, referred to as the 
parasitophorous vacuole, where a series of fusion events occur that allow the vacuole to 
become the mature phagolysosome.  This is a highly acidic and hydrolase rich 
environment that allows for amastigote development. The promastigotes have survival 
techniques to allow for existence prior to this conversion, primarily LPG, secondarily 
secreted acid-phosphatase and proteophosphoglycan, all of which include the same basic 
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repeating unit structure. As amastigotes bear little LPG, these other molecules are thought 
to protect the parasite in this stage. For example, L. mexicana produces a vacuole 
approximately 70% of the size of the host, which is full of copious amounts of these 
materials (Peters, C., et al. 1997).  
 As the primary mechanism for protection for promastigotes, LPG has been 
investigated using LPG defective mutants that are unable to establish infection in the 
macrophage phagolysosome. Mutants of L. donovani with LPG shorter than 5 repeating 
units are unable to inhibit phagosome-endosome fusion (Desjardins, M. and Descoteaux, 
A. 1997). Mutants lacking repeating units have also been shown to have the 
phagolysosome rapidly mature and acquire rab7 and LAMP1, markers for this 
maturation, while wild-type promastigotes do not (Scianimanico, S., et al. 1999).  
 The importance of LPG in establishing infection within the macrophage has also 
been shown by immunofluorescence and anti-LPG antibodies appearing on the cell 
surface within 5-10 minutes post-infection (Tolson, D.L., et al. 1990).  L. donovani 
promastigotes are thought to inhibit the phagosome-endosome fusion mentioned above 
through steric hindrance. During endocytosis, LPG molecules are shed, and they 
intercalate into the outer leaflet of the plasma membrane of the phagosome (Miao, L., et 
al. 1995).  
D. Inhibition of hydrolytic enzymes 
 While there is a dramatic decrease in the amount of LPG produced as the parasite 
transforms into the amastigote stage, the relatively small amount produced may still be 
important. The conversion results in a decrease of LPG from a few million molecules per 
cell to less than 1000 in the amastigote. Some data have suggested that LPG blocks 
lysosomal hydrolases. LPG coated erythrocytes are resistant to cytolysis compared to 
uncoated erythrocytes (Eilam, Y., et al. 1985), though no exact understanding of this 
mechanism is known.  
E. Chelation of Calcium 
 The phosphate of LPG molecules can chelate calcium, which may have important 
impacts on the survival of the amastigote in the macrophage. The endocytosis of LPG 
coated blood cells, resistant to cytolysis, show an increase in intracellular calcium, 
possibly through LPG binding. The binding of calcium to LPG does not disturb the 
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structure, and this would impair signal transduction, critically through protein kinase C 
(Eilam, Y., et al. 1985;Homans, S.W., et al. 1992;Kane, M.M. and Mosser, D.M. 2000). 
Other evidence has shown LPG can chelate other ions as well, particularly divalent 
cations, preventing production of radicals during the oxidative burst (Turco, S.J. and 
Descoteaux, A. 1992). 
F. Inhibition of Host Signaling Pathways 
 Leishmania parasites have many unique strategies to disrupt the function of the 
macrophages and turn off the microbicidal functions. Leishmania parasites and their LPG 
have been shown to interrupt the oxidative burst and radical synthesis, modulate 
macrophage apoptosis, inhibit antigen presentation and T-cell stimulation, nitric oxide 
production, and interfere with IL-12, INF-γ, and TNF-α. LPG is selective for the 
regulatory domain only. The regulatory domain allows for binding of diacylglycerol, 
calcium, and phospholipids; the 1-O-alkylglycerol moiety of LPG is the most effective 
inhibitory factor. In vitro LPG inhibits protein kinase C (McNeely, T.B. and Turco, S.J. 
1987).  There is some inhibition of PKC from the repeats, but LPG is required to be intact 
for this, individual repeating units do not work (McNeely, T.B., et al. 1989).  An 
alternative hypothesis has been presented that LPG disturbs the lipid bilayer and alters 
the properties, preventing PKC insertion and subsequent activity (Giorgione, J.R., et al. 
1996). This is a possibility as it inhibits PKC from an opposing monolayer. LPG 
mediated inhibition may disrupt other PKC-dependent events , including c-fos gene 
expression and macrophage chemotaxis (Descoteaux, A. and Turco, S.J. 1999). GIPLs 
also inhibit PKC, but as they have no repeating units, they most likely act through a 
different mechanism.   
 The nitric oxide produced by macrophages is a key regulator in pathogen 
destruction through the induction of inducible nitric oxide synthase in response to signals 
from invaders such as lipopolysaccharide. LPG-like treatment inhibited nitric oxide 
synthesis in a time and dose dependent manner (Proudfoot, L., et al. 1995a). Full length 
LPG had no effect, but repeating units alone diminished the production of nitric oxide 
(Proudfoot, L., et al. 1996). LPG associated protein kinetoplast membrane protein 11 
decreased iNOS activity due to its similarity to L-arginine, a known inhibitor of iNOS 
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(Jardim, A., et al. 1995). Production of nitric oxide is directly correlated with inhibiton of 
leishmanicidal activity.  
G. Oxidative Burst Metabolite Scavenging 
Macrophages use the synthesis of arachidonic acid metabolites and oxidative 
metabolism as its key regulators for killing foreign organisms. NADPH oxidase is the 
primary source as it produces super-oxide and hydrogen peroxide (Nathan, C. and Shiloh, 
M.U. 2000). The Gal(β1,4)Man(α1)-PO4 repeat units of LPG may protect the 
promastigote from the oxidative burst by scavenging the cytocidal products (Chan, J., et 
al. 1989;el-On, J., et al. 1990). 
H. Cytokines 
Manipulation of cytokine production alters the immune response to the invasion 
of Leishmania parasites, and protects the parasite by altering antigen presentation.  
Leishmania infected macrophages do not produce IL-12, without which there is no INF-γ, 
and no helper T-cell differentiation.  Leishmania selectively inhibits IL-12 production, 
thought to be a response as excess IL-12 may cause tissue damage detrimental to the 
parasite and its survival. LPG selectively suppresses cytokine production as inhibition of 
IL-1β gene transcription by LPG as a gene silencer through a specific sequence within the 
IL-1β promoter (Hatzigeorgiou, D.E., et al. 1996).  
6. LPG Biosynthesis
A. Core-Lipid Biosynthesis 
Biosynthesis of the lipid portion of LPG is not well understood, though it is 
proposed to begin with the formation of a 1-O-alkyl-2-acyl-phosphatidylinositol. Early 
data (Hart, D.T. and Opperdoes, F.R. 1984) suggest this begins with the use of dihydroxy 
acetone phosphate acyltransferase (DHAP) which acylates the C-1 position of the lipid. 
Reduction by NADPH and acylation at the C-2 results in the formation of 1-O-alkyl-2-
acyl phosphatidic acid. On the cytoplasmic side of the endoplasmic reticulum, a 
glucosamine unit is added and a flippase transfers it to the luminal leaflet where a 
mannosyltransferase adds a Man(α1,4) unit. It has been suggested that up until this point, 
the synthesis of GPI anchors for proteins and LPG is the same (Ralton, J.E. and 
McConville, M.J. 1998). LPG synthesis continues in the Golgi where the second 
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mannose is added to the core. A unique galactosylfuranose residue is then added (Ilgoutz, 
S.C., et al. 1999), and synthesis is continued with the addition of two more galactose 
molecules to give a final core structure of Gal(α1,6)Gal(α1,3)Galf(β1,3)[Glcα1-
PO46]Man(α1,3)Man(α1,4)GlcN(α1,6). At some stage during this process, fatty acid 
remodeling occurs, losing the C-2 fatty acid to yield the mature 1-O-alkyl-2-lyso-
phosphatidyl(myo)inositol anchor. While having structures similar to this point, GIPLs 
are synthesized via a different pathway, where the intermediates are controlled and 
isolated from the copious production of LPG (Proudfoot, L., et al. 1995b).  
B. Repeating Unit Biosynthesis 
 The start of repeating unit biosynthesis begins with an initiating 
mannosylphosphoryltransferase (iMPT). The iMPT recognizes the Gal(α1,6)Gal of the 
core, the same motif found in stachyose. Mannose-phosphate transfer has been shown to 
be most likely localized to the golgi, as all studies have shown the necessary GDP-
Mannose transporter is localized in the golgi (Figure 1.4). The activity was first 
characterized by Mengeling and Turco (1997), and has been shown to be downregulated 
in amastigotes.  An in vitro assay performed by Carver and Turco (1992) established that 
repeating unit biosynthesis continues by alteration of two enzymes; the 
mannosylphosphoryltransferase and a galactosyltransferase. 
 The continuing synthesis of repeating units requires the use of an elongating 
mannosylphosphoryltransferase (eMPT), shown to be different than an iMPT activity 
through the use of the ricin-resistant mutant JEDI (Descoteaux, A., et al. 1998). The 
eMPT recognizes Gal(β1,4)Man (Figure 1.4). There is a third 
mannosylphosphoryltransferase present responsible for the addition of the Man-P to the 
serine of proteoglycans (Moss, J.M., et al. 1999). The eMPT has been shown in a number 
of species, including L. donovani, to require the negative charge of a phosphodiester, the 
C-6 hydroxyl of the α-mannosyl residue and C-6’-hydroxyl of β-galactosyl residue for 
substrate recognition (Brown, G.M., et al. 1996;Routier, F.H., et al. 2000). While there is 
a consensus that there are 3 MPTs, there is a running debate over the existence of two 
separate eMPTs: one required for the addition of repeating units to form the procyclic 
length of 15 units and a separate enzyme that adds the repeating units required for 
metacyclic production. If there is not a second eMPT, there is an extensive regulatory 
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mechanism of the single eMPT controlling the number of repeating units during the life 
cycle. 
C. Cap Biosynthesis 
 The terminating repeating unit of the LPG molecule is referred to as the cap, the 
creation of which involves the same enzymes, and can range from a single mannose to a 
full repeating unit. In the L. donovani (Sudanese isolate) there can be a oligo-mannosyl 
cap produced, linked α1,2 to the terminal repeating unit mannosyl residue. Other strains 
of Leishmania produce different cap variants based on the side-chain glycosyltransferases 
the parasite uses in the production of its LPG, which are discussed below.  
D. Side Chain Biosynthesis 
 As mentioned previously there are three types of LPG: Type I has no side chains, 
such as L. donovani, Type II has side chains on the C-3 of the galactose, and Type III has 
side chains on the C-2 of the mannose. The only Type III LPG characterized to date is 
found on L. aethiopica which adds α-mannosyl chains. The only side chain 
glycosyltransferases characterized are those of Type II, adding side chains to the C-3 of 
the galactosyl residue. Side chain glycosyltransferases are critically regulated, as the 
eMPTs, their presence or absence affects vector choice and competence. Recently in the 
case of L. major, it has been identified that in certain vectors where the insect lectins 
aren’t directly recognizable to the side chains of L. major, there is an entirely different 
mechanism for mid-gut binding used by the parasite. In most vectors, the LPG must 
match insect mid-gut lectins. 
 The best studied group of side-chain glycosyltransferases are those involved in 
the addition of the side chains in L. major (Ng, K., et al. 1996). These have been shown to 
act on nascent LPG after synthesis of the primary glycan chain, as L. donovani LPG is 
used as the acceptor in the in vitro assays. A family of 14 genes from L. major have been 
identified, and only a number of these will be active when transferred into L. donovani 
(Dobson, D.E., Scholtes, L.D., et al. 2003). L. major has an additional 
arabinosyltransferase for side chain synthesis (Dobson, D.E., et al. 2003a;Goswami, M., 
et al. 2006) to add arabinosyl caps to the side chains as they proceed to stationary phase. 
In non-permissive vectors, the addition of this arabinose allows for the release of the 
parasite for galectins in the insect gut to continue infection. The regulation of both of 
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these are critical. L. donovani (Indian isolate) also produces type II LPGs, containing one 
or two β-linked glucoses added to the C-3 of the galactose (Mahoney, A.B., et al. 1999). 
These are developmentally regulated, as it has been shown that the activity and presence 
of glucose is downregulated in the progression to stationary phase, and affects the 
binding of the parasite to the midgut of the sand-fly.  
 
7. lpg- mutants, their selection and complementation  
The L. donovani genome was only recently sequenced and many difficulties were 
encountered attempting to create knockout parasites due to the life cycle (Gueiros-Filho, 
F.J. and Beverley, S.M. 1997), thus identification of genes in the lipophosphoglycan 
biosynthesis pathway was accomplished using mutagenesis (Figure 1.5). Parasites were 
harvested and incubated with N-methyl-N-nitroso-N’nitroguanidine (MNNG) 
(Iovannisci, D.M. and Ullman, B. 1984;King, D.L. and Turco, S.J. 1988). Mutants were 
then selected for using RCA 120, ricin agglutinin, which recognizes terminal β-galactosyl 
residues.  The parasites were subjected to multiple rounds of selection with ricin, and 
isolated as single cells. Parasites not bound by ricin agglutinin were assumed to be 
deficient in LPG synthesis, or lpg-. Structural and enzymatic analysis of these mutants 
was performed to determine their suspected defect. A suitable cosmid was developed a 
30kB extrachromosomal vector containing a selectable marker termed cLHYG for 
transformation of Leishmania parasites via electroporation (Ryan, K.A., et al. 1993a). 
Cosmid libraries could be placed into this vector, which holds approximately 40kbp of 
DNA, allowing for the entire genome to be screened using only 1000 cosmids total. 
Hygromycin was used to select for parasites that contained the cosmid and mutants that 
had corrected LPG structures could then be selected. The cosmids are then removed and 
shuttled back into E. coli for propagation and screening for open reading frames. Later 
variations allowed for creations of single knock out mutants and add backs in L. major 
after manipulation of the mutations in the L. donovani.  
R2D2 was the first of the mutants selected after mutagenesis with MNNG to be 
studied. The structure of the LPG was found to terminate just prior to the addition of the 
galactosylfuranose to the core. The parasites still survived in macrophages, did not 
produce any full-length LPG (King, D.L. and Turco, S.J. 1988). Further studies of these 
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parasites identified LPG1, a galactosylfurasyltransferase unique to the parasites (Huang, 
C. and Turco, S.J. 1993;Ryan, K.A., et al. 1993b).  
C3PO was the second mutant studied. C3PO lacked the addition of any repeating 
units to the core. Complementation identified LPG2, a GDP-Mannose transporter 
(Descoteaux, A., et al. 1995;Ma, D., et al. 1997). While initial studies suggested LPG2 
might be a single subunit of the GDP-Man transporter, further studies established that the 
GDP-Mannose transporter was a hexameric complex of LPG2 subunits capable of not 
only transferring GDP-Mannose into the golgi complex, but capable of transferring GDP-
Arabinose and GDP-Fucose as well (Hong, K., et al. 2000). This was a critical 
identification, as C3PO was not deficient in N-glycosylation, but only in LPG synthesis. 
While LPG2 was found in L. donovani, other strains of Leishmania can incorporate 
fucose and arabinose into their LPG.  
OB1 was the third mutant characterized. The structure of OB1 LPG consisted of 
only the first half of a repeat unit, Man(1)-PO4 attached to the core. Complementation 
identified OB1 to be defective in LPG3, a homolog to the mammalian chaperone GRP94 
(Descoteaux, A., et al. 2002). Like GRP94, it localized to the endoplasmic reticulum, but 
unlike anything known to have a function with mammalian GRP94, it showed a defect in 
production of all glycoconjugates, particularly that of LPG and GPI-anchored proteins. 
There were no growth defects, but unlike anything seen with a mammalian chaperone, 
GRP94 mRNA was developmentally regulated, but not regulated through heat or stress. 
LPG3 might be a GRP94 homolog, but has a completely unique function compared to its 
mammalian counterpart.  
JEDI was the mutant with the last gene characterized. While originally JEDI had 
been selected by using ricin, it became quickly obvious that JEDI ended in a terminal 
galactose. JEDI has a single complete repeating unit added to the core, but not any others, 
and thus further studies with JEDI used CA7AE, an antibody that recognizes the LPG 
repeating unit to further purify JEDI out of any potential revertants prior to analysis 
(Descoteaux, A., et al. 1998). JEDI was complemented using LPG4A, and was the first 
mutant to concretely establish that the iMPT and eMPT activities were in fact discrete 
entities. LPG4A complementation of JEDI lead to a further understanding of the genes in 
the context of MPT activities. Further analysis of JEDI identified that it wasn’t just 
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defective in one gene, but it was defective in another later to be identified as LPG4C. 
LPG4A and LPG4C were located on the chromosome next to each other, and are fused 
together.  
 
8. Current studies on LPG4A, LPG4B, and LPG4C 
LPG4A, LPG4B, and LPG4C have since been individually knocked out in L. 
major. Work on these mutants has shown LPG4A to have no defects in LPG synthesis, 
but defects in other phosphoglycans. LPG4C produces LPG similar to JEDI, and LPG4B 
can not add the first repeating unit to the core. Enzymatic analysis show LPG4B is most 
likely the iMPT, as iMPT activity using stachyose as the acceptor is completely 
obliterated in that mutant. Surprisingly, LPG4A and LPG4C knockouts, while retaining 
iMPT activity, show a marked decrease in iMPT activity. These mutants show no 
difference in the galactosyltransferase activity, suggesting this is likely do to the absence 
of each of these individual enzymes suspected to be in a complex. LPG4C knockouts 
have an absence of eMPT activity, while there is no obvious change in eMPT activity in 
LPG4A knockout. All of these are consistent with their suspected functions based on 
their structures. A mutant lacking LPG4C but with an additional copy of LPG4A rescues 
LPG synthesis based on LPG structure (Beverley et.al, personal communication), similar 
to the rescuing of JEDI by LPG4A alone, even though LPG4A is not outright involved in 
LPG synthesis. A summary of all mutants is found in Table 1.1.  
 
9. Overview of Dissertation 
  The repeating units of Leishmania LPG are a structural motif not found in 
humans. The number of repeating units on LPG is highly regulated and controlled, and is 
critical to the parasites life cycle, critical to the infectivity of the parasite, and can alter 
the innate immune response. The importance and uniqueness of the repeating units makes 
them a key chemotherapeutic target, and stresses the importance on the understanding of 
the biosynthesis of LPG. 
 There are a number of critical enzymes in LPG biosynthesis, but MPTs are key as 
they add the unique Man(α1)-PO4. There are 3 MPTs minimum to the formation of LPG, 
an initiating, an elongating, and a serine-specific.  Another key regulator in the life cycle 
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are the side chain glycosyltransferases which can affect vector specificity and immune 
response.  
 Mutagenized parasites and their functional rescue have been key to understanding 
LPG biosynthesis, and the mutants themselves are critical to understanding the structural 
formation LPG takes while on the cell surface to cause ricin resistance. JABBA, a 
parasite selected for resistance to ricin after mutagenesis with MNNG, in preliminary 
LPG analysis showed an increase in the number of repeating units in logarithmic phase 
and an increase in cap isoforms. This dissertation aims to full characterize the LPG, 
analyze the enzymes responsible for these changes, and examine the causes of ricin 
resistance. The central hypothesis is  an upregulation of key enzymes resulting in the 
increase in repeating units and additional cap isoforms, and that addition of repeating 
units affects ricin resistance. 
JABBA shows two key differences in the structure of LPG from wild-type; the 
number of repeating units and the cap structures. Wild-type L. donovani (Sudanese) has 
15 repeating units in logarithmic phase, and 30 repeating units in stationary phase, while 
JABBA LPG has 30 repeating units in logarithmic phase, and 47 in stationary phase, with 
a quantifiable length shift in mid-logarithmic phase. JABBA LPG has 3 unique cap 
structures found only in logarithmic phase: Glc(β1,2)Man, Gal(β1,4)[Glcβ1,2]Man, and 
Gal(β1,4)[Glcβ1,2Manα1,2]Man.  
 The potential enzymes causing these changes, including the iMPT, eMPT, and β-
glucosyltransferase were investigated. JABBA had no change from wild-type in iMPT 
activity, but showed a doubling in both eMPT and β-glucosyltransferase activity. Product 
characterization of the β-glucosyltransferase activity of both JABBA and wild-type 
parasites revealed a Gal(β1,4)[βGlc]Man product on L. donovani LPG in both parasites, 
resembling the structure of the unique trisaccharide cap in JABBA parasites. Wild-type 
has no in vivo activity, but this reveals the presence of a post-translationally regulated 
glucosyltransferase that differs from the L. donovani (Indian isolate) β-
glucosyltransferase. 
 While terminating in galactose, the LPG was still ricin resistance. Logarithmic 
and stationary phase parasites were checked for agglutination by ricin, peanut agglutinin, 
and concanavalin A and susceptibility to galactose oxidase. While parasites in all phases  
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showed increased resistance compared to their wild-type counterparts, stationary phase 
parasites showed the greatest resistance, showing the number of repeating units was 
causing the cap to go cryptic, masking the terminal galactose. This work furthers 
previous research in this area, as the caps are most likely to be inaccessible are in 
parasites with LPG longer than 30 repeating units. 
 The work in this dissertation furthers the studies on regulation of the biosynthesis 
of Leishmania LPG. Regulation of the eMPTs is critical to developing 
chemotherapeutics, and JABBA may hold the key to understanding the differences 
between Sudanese and Indian isolates of L. donovani. Overall, JABBA allows for a 
unique view into the parasites life cycle not seen previously. 
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Table 1.1. Summary of mutants and their identified gene mutations. 
 
 
Mutant LPG Structure Gene Mutation Function 
R2D2 Man-Man-GlcN-PI LPG1 Point Galf Transferase 
C3PO Core-PI LPG2 Deletion GDP-Man Transporter 
OB1 Man-PO4-Core-PI LPG3 Point Chaperone 
JEDI Gal-Man-PO4-Core-PI LPG4A Deletion - 
LPG4A-/- No Change - K.O. PPG eMPT 
LPG4B-/- Core-PI - K.O. iMPT 
LPG4C-/- Gal-Man-PO4-Core-PI - K.O. eMPT 
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Figure 1.1. Life cycle of Leishmania species: adopted from (Bray, A. 1999) 
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Figure 1.2 Structures of the Leishmania glycocalyx. Large circles represent proteins, 
small clear circles represent phosphoglycans. The triangles are caps, and the rectangles 
represent a conserved glycan core attached to the representative phospholipid.  
24 
 
 
 
 
 
Figure 1.3. The LPG structures of a number of Leishmania species (Bray, A. 1999). 
a. (Turco, S.J., et al. 1987) b. (McConville, M.J., et al. 1990) c. (Ilg, T., et al. 1992) d. 
(McConville, M.J., et al. 1995) 
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Figure 1.4. The reactions to synthesize the major carbohydrate component of LPG. 
These reactions take place in the golgi apparatus. The eMPT and GalT trade off until the 
molecule is complete. Some species, such as the Indian strain of L. donovani have an 
addition of side chains, which are believed to be added after the repeating units are added 
to the molecule. iMPT: initiating mannosylphosphoryltransferase, eMPT: elongating 
mannosylphosphoryltransferase, GalT: galactosyltransferase, β-GlcT: β-
glucosyltransferase 
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Figure 1.5 A diagram representing the methodology for mutagenesis of parasites 
and identify those deficient in LPG synthesis.  
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Chapter II 
Materials and Methods 
1. Materials and Equipment 
A. Materials 
Chemicals and reagents were obtained as follows: Bacto- Brain Heart Infusion. 
(Difco). Alkaline Phosphatase (E.coli), Beta-glucosidase (Almond), Beta-galactosidase 
(E.coli) , Alpha Mannosidase (Jack Bean), ANTS (8-Aminonaphthalene-1,3,6-trisulfonic 
acid) from Sigma , feta bovine serum (Atlanta Biologicals), APTS (8-aminopyrene-1,3,6-
trisulfonate) labeling and capillary electrophoresis columns (Ab-Sciex), C-18 Sep-Pak 
columns (Waters), BCA Reagent Kit (Pierce), and Protease Inhibitor (Roche).  
B. Equipment 
Centrifuges: Heraeus Biofuge Pico, Sorvall RC-5B, Sorvall M120-SE ultra. 
Incubators: Fisher Brand, Low Temperature Incubator (small scale), New Brunswick 
Scientific C-25 shaking incubator. Evaporator: Savant SpeedVac Plus, Organomation 
Nitrogen Evaporator, N-EVAP#112. Capillary Electrophoresis: Beckman P/ACE MDQ 
2. Parasites and Mutagenesis 
A. Parasites 
L. donovani (MHOM/SD/00/1S-2D) , L. donovani (MHOM/IN/83/Mongi-142), 
and JABBA were maintained in M199 with 10% FBS as described previously (Kapler, 
G.M., et al. 1990). 
B. Mutagenesis 
Parasites were selected and mutagenized as described previously (King, D.L. and 
Turco, S.J. 1988). The cell concentrations used in ricin selection were between 2 x 106 
and 2 x 107 cells/ml.   
3. Purification and analysis of LPG 
A. Purification of LPG 
Logarithmic phase JABBA promastigotes were extracted at 5.0 x 105 to 1.0x 106 
parasites per milliliter from brain heart infusion supplemented with heme and adenosine 
(Orlandi, P.A., Jr. and Turco, S.J. 1987). LD4 and Mongi were extracted at 3.0 x 106 to 
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6.0 x 106 parasites per milliliter for logarithmic phase. All strains were extracted at 
greater than 2.0 x 107 parasites per milliliter for stationary phase.  
 Logarithmic parasites were extracted using the Ferguson method as detailed 
previously (Proudfoot, L., et al. 1996) using two 2 mL 4 h washes in 
methanol/chloroform/water (2:1:0.8) to remove various glycolipids followed by two 0.5 
mL washes in 9% 1-butanol collected after 30 min of water bath sonication.  Purification 
of these fractions on octyl-sepharose chromatography, using a 60% propanol gradient. 
Fractions were spotted on silica thin layer chromatography plates and sprayed with 
orcinol and sulfuric acid and subsequently charred in a 100°C oven for approximately 8 
min to identify the LPG containing fractions. 
 Stationary parasites were extracted by the Folch method (McConville, M.J., et al. 
1990;Orlandi, P.A., Jr. and Turco, S.J. 1987). After centrifugation, pellets were washed 
twice with PBS, twice with chloroform/methanol/water (3:2:1), three times with 4 mM 
MgCl2 and three times with solvent E (water/ethanol/diethylether/pyridine/NH4OH, 
15:15:5:1:0.017) to purify and collect LPG, then dried under N2. Dried material was 
resuspended in 0.1 N acetic acid/ 0.1 N NaCl (running buffer) and purified using phenyl-
sepharose chromatography. The column was equilibrated with 6 column volumes running 
buffer, then crude LPG was applied. The column was then rinsed with 6 column volumes 
running buffer, 4 column volumes 0.1 N acetic acid and 1 column volume water. The 
LPG was eluted with 6 column volumes solvent E and dried under a stream of N2. 
B.  Mild Acid Hydrolysis 
Dried LPG was resuspended in 150 µL 0.02 N HCl and incubated at 60ºC for 15 
min. After the mixture was dried under a stream of N2, 150 µL toluene was added and 
evaporated three times. This treatment cleaves at the phosphate of the repeating units.  
C. Butanol Partition and C18 lipid removal 
To remove the core-lipid from samples treated with mild acid hydrolysis, dried 
samples were treated with water-saturated 1-butanol (McConville, M.J., et al. 1987). The 
top (organic layer) was removed and set aside for further analyses of the core and lipid. 
The aqueous layer was dried for anionic chromatography to collect caps and repeats. If 
the lipid was not being saved, the aqueous sample could be applied to a C18 sep-pak 
column and carbohydrate collected with water.  
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D. Nitrous Deamination 
To separate the lipid from carbohydrate, purified core-lipid or whole LPG was 
dried and resuspended in 300 µL 0.25 M sodium acetate (pH 4.0) and 300 µL 0.5 M 
sodium nitrite (Ferguson, M.A., et al. 1985). The mixture was left in a water bath for 16 h 
at 37ºC.  
E. Strong Acid Hydrolysis 
To cleave between the glycosidic bonds, oligosaccharides were treated at 100ºC 
for 3 h with 2 N trifluoroacetic acid. After this treatment, desalting is required (see 
section G).  
F. Enzymatic Treatments 
  Alkaline phosphatase treatment was performed using 1U in 1 mM Tris-HCl (pH 
9) overnight at 37°C. β-glucosidase treatment was performed overnight using 1U in 200
mM ammonium acetate at 37°C. α-mannosidase treatment was performed overnight 
using 0.1 M sodium acetate pH 4.5 with 1 U at 37°C. β-galactosidase treatment was 
performed overnight with 1U in sodium phosphate buffer at 37ºC.  
G. Desalting and Anionic Exchange Chromatography 
Desalting was performed with a mixed bed of equal parts AG-50WX10 and AG1-
X8. For most small samples, a total column volume of 0.5 mL was used. For desalting 
prior to capillary electrophoresis, a 1 mL mixed bed column was used. For anionic 
exchange chromatography, a 1 mL bed of AG1-X8 was used and samples were applied 
and allowed to sit for ten min. 6 mL of water was used to collect caps, then 6 mL of 0.3 
M NaCl was used to collect repeats from samples.  
H. Stains-All  
Approximately 20 µg of LPG was run for 1 h at 120 V on 12% SDS-PAGE. The 
gel was rinsed three times for 10 min in 25% isopropanol and left immersed for 
approximately 16 h. The isopropanol was poured off, and the gel was incubated in stains-
all solution (64.5% water, 25% isopropanol, 5% foramide, 5% stains-all, 1% water) for 2 
h (Bahr, V., et al. 1993). The gel was destained in 40% ethanol until visualization. 
I. Fluorophore Assisted Carbohydrate Electrophoresis. 
Oligosaccharide fluorophore assisted carbohydrate electrophoresis was used 
following the method of Lehrman and Gao and the subsequent modifications (Gao, N., et 
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al. 2013;Lehrman, M.A. and Gao, N. 2003). The resolving gel stock was 38% 
acrylamide/ 2% bis-acrylamide with a buffer of 1.5 M tris-chloride (pH 8.9). The 
stacking gel was 10% acrylamide, 2.5% bisacrylamide, with a buffer of 1.0 M tris-
chloride (pH 6.8). Samples were labeled with 0.15 M ANTS in 15% acetic acid and 1 M 
sodium cyanoborohydride in DMSO overnight at 37ºC. The gel was run at 20 mAmps 
and 4ºC for approximately 3 h until it reached the bottom. A glucose standard ladder of 
oligosaccharides was used.  
J. Separation of Monosaccharides via Capillary Electrophoresis 
Samples were labeled using 2 µL monosaccharide APTS and 2 µL 1M sodium 
cyanoborohydrirde in THF for 90 min at 55°C.  Before loading into the unit, 196 µL of 
water was added to the samples. The capillary was conditioned for 2 min with 0.1 N 
NaOH and then 0.1 N HCl with a 1 min water rinse between. The capillary was coated 
for 2 min with a running buffer of 30 mM sodium borate with 5% methanol.  Samples 
were injected at a rate of 0.4 psi for 4 sec, and voltage separated for 20 min.  Standard 
curves of anhydromannose, created by nitrously deaminating glucosamine, and mannose 
were used for quantification. The sensitivity ratio between mannose and anhydromannose 
was found to be 1.5 to 1, consistent with previous results  (Barron, T.L. and Turco, S.J. 
2006). Galactose and glucose are roughly equal to mannose in sensitivities.  
K.  Separation of Oligosaccharides via Capillary Electrophoresis 
Neutral desalted oligosaccharides were run through a carbohydrate coated silica 
column. They were labeled overnight using oligosaccharide APTS containing acetic acid 
and sodium cyanoborohydride in the dark at room temperature. The capillary was 
conditioned using 10 min rinse of water at 30 psi followed by a 10 min 30 psi rinse of 
carbohydrate buffer. The column was coated with gel buffer for 5 min at 20 psi before 
applying samples. The ladder was injected for 0.4 sec at 0.4 psi and separated at a 
maximum of -25 kV for 20 min with reverse polarity. For product characterization of the 
glucosyltransferase assay, the sample injection rate was 5 psi for 5 sec. For every other 
visualization, 0.4 psi for 4 sec was used. (Soares, R.P.P., et al. 2004) 
L. Partially Methylated Alditol Acetates 
The structure of the cap isoforms was determined using partially methylated 
alditol acetates, adapted from the previously published protocol (Pettolino, F.A., et al. 
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2012). Material was dried in a speed vacuum concentrator then resuspended in methanol 
and evaporated twice. 50 µL of DMSO was applied to the sample in a screw top tube and 
placed in a sonicating water bath for 30 min. Approximately 50 µL of slurry of NaOH in 
DMSO was applied via capillary pipette to the sample and sonicated again for 30 min in 
the water bath. Three applications of iodomethane were applied with two 10 µL, 10 min, 
sonication applications and a 20 µL, 20 min, application. The methylated product was 
extracted using dichloromethane and water. The dichloromethane soluble portion was 
dried and resuspended in 250 µL 2 N TFA in a 100ºC oven for 90 min. The sample was 
dried and resuspended in 50 µL 2 M ammonium hydroxide. A 1 M solution of sodium 
borodeutride in 2 M ammonium hydroxide was freshly prepared and 50 µL applied to the 
sample and allowed to incubate at room temperature for 2.5 h. The samples were then 
evaporated with methanol in 5% acetic acid twice, followed by two rinses of methanol. 
250 µL of acetic anhydride was applied to the samples in a 100ºC oven for 2.5 h. After 
removal from the oven, the sample was allowed to cool and 2 mL of water was added. 
The samples were then extracted with 1mL of dichloromethane and cleaned with 2 mL of 
water twice.  The dichloromethane was then collected and dried under a stream of N2 
carefully. The sample was resuspended in an appropriate amount of dichloromethane and 
sent to the UK Mass Spectrometry facility for analysis via gas chromatography-mass 
spectrometry.  
The GC-MS was performed by the UK Mass Spectrometry facility on a Shimadzu 
GCMS-QP5000 (quadrupole mass spectrometer) equipped with a GC-17A gas 
chromatograph. Electron ionization (EI) mass spectra were recorded at 70eV, scanning 
m/z 45-550 at ~1 scan/sec. The GC column was a DB-5ms (Agilent/J&W) 30m x 
0.25mm (0.25 um df) with helium as the carrier gas. The column oven temperature 
program was 50°C (1 min initial hold) to 280°C at 10°C/min, with an injector temperature 
of 250°C and an interface temperature of 280°C. 
M. Lipid Analysis 
For purification of the lipid for thin layer chromatography, whole LPG was 
treated with mild acid. A butanol partition was then performed collecting the butanol and 
drying it under a stream of N2. Collected product was nitrously deaminated to cleave the 
lipid overnight at 37ºC. Product was subject to another butanol partition, dried, then 
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resuspended in 0.1N HAc/NaCl and purified via phenyl sepharose chromatography, 
collecting the final solvent E fraction. Thin layer chromatography of the nitrously 
deaminated lipid was performed as described previously using silica gel 60 TLC plates 
and developing with CHCl3: CH3OH: 4.2 N NH4OH (9:7:2) system.  Additional controls 
used on the plate included phosphatidylinositol, phosphatidylcholine, and previously 
purified alkyl-lyso-phosphatidylinositol in addition to L. donovani and JABBA purified 
lipids.  (Mahoney, A.B., et al. 1999;Orlandi, P.A., Jr. and Turco, S.J. 1987).  
4. Enzymatic Assays
A. Preparation of Microsomal Membranes.   
Microsomal membranes were prepared as previously described (Mengeling, B.J., 
et al. 1997b), with the following modifications:  Cultures of parasites (200 m) were  
centrifuged at 2700 rpm for 7 min, and resuspended in 10 mL of lysis buffer containing 
100 mMol HEPES  (pH 7.4), 50 mMol KCl, 1 mMol EDTA (pH 8.0), 10% glycerol, and 
protease inhibitor.  The suspension was subjected to nitrogen cavitation using a Parr 
bomb for 30 min at 1500 psi on ice. Subsequent centrifugations took place at 4°C for 
3000 x g, 10000 x g for 10 min, and 100000 x g for 1 h.  The supernatant was removed, 
and the pellet was resuspended in membrane buffer containing 100 mMol HEPES (pH 
7.4), 50 mMol KCl, 1 mMol TLCK, and 1 µg/ml leupeptin using a homogenizer.  The 
final protein concentration was determined with a BCA reagent kit.  
B. Initiating Mannosylphosphoryltransferase (iMPT) Assay  
The iMPT in vitro assay was performed as previously reported (Mengeling, B.J., 
et al. 1997b) with the following modifications. The assay mixture contained 1 mg 
membrane protein, 15% glycerol, 2.5 mMol thioglycerol, 10 mMol MnCl2, 5 mMol 
MgCl2, 4 mMol dithiothreitol, 800 µMol GDP-Man, and 27 nCi per4 mMol stachyose in 
100 µL. The mixture was incubated for 4 h at 30°C and the reaction was terminated on 
ice.  Product purification was performed as previously detailed (Mengeling, B.J., et al. 
1997b) and radioactivity was counted via scintillation.  
C. Elongating Mannosylphosphoryltransferase (eMPT) Assay 
The eMPT assay involved the preparation of soluble proteins from the 
microsomal preparations. These soluble microsomal proteins were prepared with final 
concentrations of 50 mMol HEPES (pH 7.5), 150 mMol KCl, 10 mMol MnCl2, 5 mMol 
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MgCl2, 20% glycerol, 1 µg/ml leupeptin, and 0.5% dodecyl-maltoside and 3 mg of 
microsomes.  The microsomal mixture was rotated for 1 h at 4°C and then centrifuged at 
100,000 x g for 1 h. The supernatant collected was used for the eMPT assay. 
The eMPT activity was quantified as done previously (Carver, M.A. and Turco, 
S.J. 1991) with the following modifications using an assay mixture of 1 mMol ATP, 0.5 
mMol dithiothreitol, 2 mMol GDP, 10 mMol MnCl2, 5mMol MgCl2, 225 nCi of [3H]-
GDP-Man at 200 µMol and 75 µL solubilized microsomal protein in a total of 150 µL.  
An exogenous acceptor (25 µg) of JEDI LPG (Descoteaux, A., et al. 1998), possessing a 
single Gal-Man-PO4 repeat on the glycan core-PI, was used.  The assay mixture was 
incubated for 1 h at 28°C. The reaction was terminated with 0.5 M EDTA and the 
radioactive product was purified via chromatography on phenyl-sepharose and product 
containing fractions were determined by scintillation counting.  
D. β -Glucosyltransferase Assay 
The glucosyltransferase assay was quantified using 0.5 µCi of 34 µMol UDP-Glc 
in the same final volume as previously described(Mahoney, A.B. and Turco, S.J. 1999).  
LPG was extracted, and total radioactivity was counted via scintillation.  
E. Product Characterization of β -Glucosyltransferase Assay  
For product identification, the product from nonradioactive β-glucosyltransferase 
assays, along with assays lacking UDP-Glc and exogenous LPG were desalted on a 
mixed bed column (2 mL) of AG-50W and AG1-X8 then dried.  One aliquot of the 
product was treated with mild acid as described previously, then desalted.  Another 
aliquot was treated with mild acid hydrolysis and dephosphorylated with alkaline 
phosphatase, then desalted.  The samples were then reductively labeled overnight with 
APTS and sodium cyanoborohydride in THF in the dark at room temperature.  Product 
obtained after mild acid and alkaline phosphatase was also analyzed by exoglycosidase 
treatments.  For analysis by oligosaccharide capillary electrophoresis, injection pressures 
were 5 psi for 5 sec (Soares, R.P., et al. 2004) unless otherwise stated.  
5. Resistance Assays
A. Lectin Assays  
For 30 min, 5.0x106 cells were rocked in 5 mL of M199 containing 100 µg of 
peanut agglutinin, RCA 120 (ricin agglutinin), or concanavalin A. 10 µL of cells were 
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placed on a hemacytometer and free cells were counted.  The parasites were selected in 
logarithmic phase at a culture density of less than 1.0 x 106 cells and in stationary phase 
at a minimum of 1.0 x 107 cells. 
B. Galactose Oxidase Treatment.  
1.0 x 109 logarithmic and stationary cells from L. donovani and JABBA were 
treated with 3U galactose oxidase in 500 µL PBS at 25°C for 1 h (Sacks, D.L., et al. 
1995). LPG was collected and purified using the Folch method. Caps were isolated after 
mild acid hydrolysis, butanol partition, and separation of AG1X-2 using the charge, then 
dried in a speed vacuum concentrator. Caps were then treated with 2 N TFA in a 100°C 
oven for 3 h, and desalted as described above. The caps were dried and labeled as 
described for monosaccharide capillary electrophoresis. A 75 µM bare fused silica 
capillary was run at 20 kV using a 15 mM sodium borate, 2.5% methanol buffer for 10 
min. The percent of galactose available for reaction with galactose oxidase was 
calculated using caps collected in the same fashion, and normalizing to the areas of 
mannose. The percentage galactose available was calculated as the total area of galactose 
found in galactose-oxidase treated cells to those that were not. 
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Chapter III 
 The Structure of the Lipophosphoglycan of JABBA parasites 
1. Introduction
Leishmania parasites have a unique life cycle that requires an extensive 
glycocalyx for protection from the sand-fly gut, complement in the bloodstream, and the 
mammalian phagolysosome (Kaye, P. and Scott, P. 2011). Lipophosphoglycan, one 
component of the Leishmania’s glycocalyx, is critically regulated throughout this life 
cycle as it progresses from procyclic promastigote through metacyclic promastigote to 
amastigote (de Assis, R.R., et al. 2012). Lipophosphoglycan is the dominant glycocalyx 
molecule in the promastigote stage, and most frequently studied there.  
The Leishmania genome has only recently been sequenced (Ivens, A.C., et al. 
2005), so earlier attempts to identify genes involved in biosynthesis of LPG involved 
chemical mutagenesis of parasites by MNNG and selection by ricin exposure to identify 
mutants defective in LPG (Iovannisci, D.M. and Ullman, B. 1984;King, D.L. and Turco, 
S.J. 1988). Critical mutants selected have been defective in LPG synthesis and identified 
four genes  (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;Hong, K., et al. 
2000;Ma, D., et al. 1997;Ryan, K.A., et al. 1993b): LPG1, a 
galactosylfuranosyltransferase,  LPG2, the GDP-Mannose transporter, LPG3, a heat 
shock protein chaperone, and LPG4A, a mannosylphosphoryltransferase. LPG4B and 
LPG4C were also identified from studies with these mutants (Beverley, personal 
communications).  JABBA is the first extensively studied ricin resistance parasite not 
defective in LPG synthesis, and is critical to determining the complete structure of LPG 
and how it differs from wild-type.  
Early data suggests that the structure of the parasites have abnormal cap isoforms, 
most likely with the addition of a β-glucose reminiscent of the β-glucose containing LPG 
of the Indian strain of L. donovani. The increase in repeating units, while not having been 
quantified, suggests the parasite may be “stuck” in metacyclogenesis, and will not 
necessarily elongate in once in stationary phase. The nature of these hypotheses will be 
discussed alongside the complete structure.  
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2. Results
The structure of lipophosphoglycan consists of a conserved core and unique 1-O-
lyso-alkyl-phosphatidylinositol, a stage specific number of Gal(β1,4)Man(α1)-PO4 
repeating units, and a terminal cap. LPG in wild-type L. donovani Sudan (LD4) averages 
15 unsubstituted repeating units in logarithmic phase and 30 unsubstituted repeating units 
in stationary phase (Barron, T.L. and Turco, S.J. 2006), while the terminal cap structure 
can vary from a single terminal mannose to a full repeating unit, occasionally with an 
additional α-mannose (Greis, K.D., et al. 1992). A schematic of L. donovani LPG is 
found in Figure 3.1. 
A. JABBA produces a much larger LPG than wild-type. 
JABBA was selected for being ricin-resistant after mutagenesis with MNNG. Most 
parasites selected through this technique produce much shorter LPG than wild-type. 
Initial quantification of total LPG estimates that JABBA produces approximately 1/3rd 
the LPG of L. donovani (LD4). Through visualization by stains-all on a 12% SDS gel, 
logarithmic phase JABBA was found to produced LPG roughly twice the size of wild-
type, similar in size to LPG in stationary wild-type. Surprisingly, in JABBA stationary 
phase LPG appears to increase in size relative to logarithmic phase. (Figure 3.2) 
B. The structure and number of the repeating units of JABBA LPG 
An increase in the size of LPG is due to either the number of repeating units or 
the addition of side chains to the repeating units.  Using fluorophore assisted 
carbohydrate electrophoresis to visualize the repeating units, L. donovani was shown to 
contain a disaccharide as expected, as did JABBA (Figure 3.3). The purified 
disaccharides were treated with strong acid hydrolysis and the individual components 
were verified to be galactose and mannose in both L. donovani and JABBA by 
monosaccharide capillary electrophoresis. (Figure 3.4) 
After verifying that the composition of JABBA’s repeating units is the same as L. 
donovani’s, it was neccessary to determine the number of repeating units present. In 
order to quantify the repeating units using monosaccharide capillary electrophoresis, the 
fluorescence ratio of anhydromannose to mannose was found to be 1.5 to 1 as previously 
published (Barron, T.L. and Turco, S.J. 2006). Standard curves were used to determine 
the total amounts of anhydromannose and mannose in a sample. An example of the CE 
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chromatogram found from analyses to determine the repeating units is found in Figure 
3.5. The number of L. donovani repeating units was determined to be 15 in logarithmic 
phase and 30 in stationary phase, matching previously published data (Sacks, D.L., et al. 
1995). Logarithmic phase JABBA LPG has 30 repeating units, 47 in stationary phase. 
Over the course of data collection, a mid-logarithmic LPG size was found to be 42. 
(Table 3.1) 
C. The structure of the caps of JABBA Lipophosphoglycan 
As JABBA LPG structure is larger than wild-type, it was critical to establish if the 
caps contained a galactose. In other mutants, ricin-resistance was confered by shorter 
LPG structures that without a terminal galactose (Descoteaux, A., et al. 2002;Huang, C. 
and Turco, S.J. 1993). Using fluorophore assisted carbohydrate electrophoresis, the cap 
structures of the L. donovani and JABBA were compared. L. donovani showed a 
disaccharide and monosaccharide, with a faint trisaccharide, reminiscent of the published 
cap structures of L. donovani  (Greis, K.D., et al. 1992). JABBA showed the same 3 
bands, plus an additional trisaccharide and tetrasaccharide (Figure 3.6).  
As FACE gels require large quantities of materialto visualize JABBA caps, 
oligosaccharide capillary electrophoresis was used to view the enzymaticly reacted cap 
structures due to its sensitivity. In L. donovani caps, one disaccharide was β-galactosidase 
sensitive, while the other disaccharide was α-mannosidase sensitive; the trisaccharide was 
sensitive to both. No L. donovani caps were β-glucosidase sensitive. This matches 
previously published data for L. donovani caps (Greis, K.D., et al. 1992), and the exact 
linkages were not pursued further.  
Capillary electrophoresis of reacted JABBA caps revealed the presence of two 
trisaccharides, one of which aligned with the trisaccharide from L. donovani.  The CE 
chromatogram of JABBA caps are found in Figure 3.7. These two structures were both β-
galactosidase and β-glucosidase sensitive, but α-mannosidase resistant. Parasites 
collected at a density greater than 3.0 x 106 parasites/ml lacked both the unique glucose-
containing trisaccharide and tetrasaccharide, matching the wild-type cap profiles.  
Monosaccharide capillary electrophoresis was used to calculate the relative ratios 
of substituents of bulk cap samples shown in Figure 3.8. The chromatograms are adjusted 
to the elution times to view the glucose. Mannose was used for normalization, as every 
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cap isoform contains a mannose in both L. donovani and JABBA caps. The comparison 
showed a similar amount of galactose in logarithmic cap samples of L. donovani and 
JABBA, but stationary JABBA cap samples showed approximately half the amount of 
galactose. Equivalent amounts of glucose and galactose were found in JABBA 
logarithmic cap samples. Combined with oligosaccharide capillary electrophoresis, the 
relative amounts of each cap isoform were calculated in Table 3.2.  
These cap structures were predicted to be Gal-(Glc)Man and Gal-(Glc-Man)Man. 
It is important to note that after both β-galactosidase and β-glucosidase treatment there 
was a decrease in the total amount of disaccharide present in the sample, suggesting there 
was a glucose containing disaccharide present. Predicted disaccharide structures include 
Man-Man, Gal-Man, and Man-Glc.  
Partially methylated alditol acetates were used to determine the linkage as the 
composition and order were already known. L. donovani has Gal (β1,4)Man, 
Man(α1,2)Man, Man, and Gal(β1,4)[Man(α1,2)]Man caps. Besides a 2,4-linked 
mannose, JABBA showed no other hinge mannose, suggesting that the linkage (Figure 
3.9) between the glucose and mannose is Glc(β1,2)Man, consistent with type-III LPG. 
Approximately 20% of the sample was terminal glucose, verifying the capillary 
electrophoresis calculations on total cap isoforms. The unique cap structures found on 
JABBA LPG were Glc(β1,2)Man, Gal(β1,4)[Glc(β1,2)]Man and 
Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man. The percentages of all structures are found in Table 
3.3. 
D. Core and Lipid Structure of JABBA LPG 
For analysis of the core, both L. donovani and JABBA LPG glycan cores were 
separated from the lipid by nitrous deamination. The primary components of each were 
identified as galactose, mannose, and anhydromannose (Orlandi, P.A., Jr. and Turco, S.J. 
1987;Turco, S.J., et al. 1989). The oligosaccharide analysis showed both as a 
hexasacharide. The monosaccharide compotents and oligosaccharide size of both JABBA 
and L. donovani matched previously published data. 
The lipid was purified on phenyl-sepharose after nitrous deamination. Thin layer 
chromatography was performed developing in a chloroform/methanol/ammonium 
hydroxide system observing L. donovani and JABBA purified lipids from LPG along 
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with standards: phosphatidylinositol, and phosphatidylcholine. The migration times were 
consistent with the published data (Orlandi, P.A., Jr. and Turco, S.J. 1987) classifying the 
structure of the lipophosphoglycan lipid. TLC plates showed approximately 8.5cm 
migration time for the lipid in L. donovani (LD4) and JABBA. Migration times are found 
in Table 3.4. 
3. Discussion
The structure of LPG throughout the life cycle of the parasite is critically 
regulated (Sacks, D.L., et al. 1995). The glycan core and alkyl-lyso-phosphatidylinsoitol 
lipid anchor are conserved in the structure (McConville, M.J., et al. 1990;Orlandi, P.A., 
Jr. and Turco, S.J. 1987;Turco, S.J., et al. 1989) and is frequently found as the basis for 
other glycolipids on the cell surface. The procyclic promastigote LPG has 15 repeating 
units consisting of Gal(β1,4)Man(α1)-P and ends in a terminal cap that can be a mannose, 
a full repeating unit, Man(α1,2)Man or a repeating unit substituted with α-mannose on 
the mannose of the repeating unit. This is all present on the C-2 of the mannose as LPG. 
Metacyclic LPG has approximately 30 repeating units, the increase in units causing the 
release from the parasite gut (Sacks, D.L., et al. 1995), and the number of repeating units 
effects many functional attributes (Gaur, U., et al. 2009).  
Besides the number of repeating units, species of Leishmania that have LPG with 
side chains are also developmentally regulated (Coelho-Finamore, J.M., et al. 2011;de 
Assis, R.R., et al. 2012;Dobson, D.E., et al. 2003b). While L. donovani Sudan doesn’t 
possess any side chains, L. donovani India has β-Glucose substituted on the C-3 of 
galactose (Mahoney, A.B., et al. 1999). The percentage of glucose decreases as the 
parasite progresses from procyclic to metacyclic form. Other species, like L. major, cap 
their side chains with other sugars as they proceed from procyclic to metacylic phase 
allowing for release of the parasite from the sand-fly gut (Dobson, D.E., et al. 
2010;Dobson, D.E., et al. 2003a).  
JABBAs LPG size increase is reminiscent of a parasite that has undergone 
metacyclogenesis in logarithmic phase. There is no obvious explanation for why it 
continues to stationary phase, contrary to the initial hypothesis that it would not elongate. 
The repeating units are the same composition as wild-type and the increase to 30 units in 
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logarithmic phase and to 47 in stationary is the primary difference between the strains. 
JABBA also shows a mid-logarithmic length of 42, a change that has not been previously 
noted in L. donovani. Depending on the assay and the total density of the parasites used, 
an increase in the average number of repeating units can be found in cultured logarithmic 
phase L. donovani. If this phenomenon is a by-product of culturing the parasite outside of 
the sand-fly is unknown. For this reason, we have defined our phases to avoid mid-
logarithmic length: logarithmic is less than 3.0 x 106 parasites/ mL, stationary is greater 
than 1.0 x 107 parasites/mL. 
In regards to the cap structure, there is the inclusion of a β-glucose similar to the 
Indian strain of L. donovani, but the acceptor has changed. Whether this is a separate 
mutation within JABBA, or the result of a novel β-glucosyltransferase inactive in LD4 
(Sudanese L. donovani) will be examined later in this work.  
The apparent down-regulation of glucose in JABBA cap isoforms is also similar 
to L. donovani India, as it  decreases the number of glucose side chains present on its 
LPG as it progresses from procyclic to metacylic phase, as this decrease is critical for the 
release of the parasite from the sand fly gut (Mahoney, A.B., et al. 1999;Mahoney, A.B. 
and Turco, S.J. 1999). This makes it the most likely explanation for the origin of the 
glucose present on the caps of JABBA, as L. donovani Sudan, the parasite that was 
originally mutagenized to create JABBA, does not have an β-glucosyltransferase active 
in vivo.  
An interesting statistic is the dramatic decrease of galactose in JABBA LPG cap 
during the progression from logarithmic phase to stationary phase. Ratios between 
mannose, galactose and glucose were calculate in wild-type L. donovani, JABBA 
logarithmic caps, and JABBA stationary caps. As mentioned above, there was no glucose 
in JABBA stationary caps, which was demonstrated by a change in the isoforms back to 
wild-type, no glucose in themonosaccharide analysis, and the caps resistantance to 
treatment with β-glucosidase. Looking at the relative ratios of mannose to galactose, 
JABBA stationary phase caps contain half the galactose of JABBA logarithmic caps and 
wild-type L. donovani. While this would be an abnormal statistic in any normal strain, 
this decrease does lead to one hypothesis on the formation of JABBA LPG. In stationary 
phase, the parasite is continuing to try to elongate its LPG; it does not have a stopping 
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point. In other words, the eMPT is essentially unregulated, the possibility exists that the 
glucose is the only regulator, as modification to the terminal-galactose molecule has been 
shown to prevent action of the eMPT (Routier, F.H., et al. 2000). 
Based on our defined points of logarithmic and stationary phase, the glucosyl 
residue is lost at approximately 3.0 x 106 parasite/ml, where we start to see the initial 
increase in size. One might believe the glucose is the only reason we see any apparent 
regulation of the eMPT in JABBA. The 47 repeating units is likely to be a stopping point 
where the parasite is physically unable to continue to elongate any further at this point. 
There is also a definite possibility that the parasite can not move LPG beyond that length 
to the surface. We know formation of the LPG takes place in the golgi, and moving large 
LPG to the surface could cause transport problems. 
There are quite a number of questions that still exist in our understanding of 
metacyclogenesis. Recently an algorithm was formulated that would allow to show there 
is a notable difference in morphology of the parasite once it has undergone 
metacyclogenesis (Berg, M., et al. 2013). While not shown here, there is a notable visual 
difference between logarithmic phase L. donovani and logarithmic phase JABBA 
parasites. The overall behavior of the parasites more closely resembles those of stationary 
L. donovani parasites; they have a greater tendency to form rosettes or stick together like 
stationary L. donovani. This behavior, combined with the structure of JABBA’s LPG, 
suggests further analyses of JABBA could lead to an understanding of the critical 
regulatory events that are required for Leishmania species to undergo metacyclogenesis.  
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Table 3.1. Average number of repeating units per molecule of LPG in L. donovani 
(LD4) and JABBA parasites based on the growth-phase. Logarithmic phase samples 
n>8, stationary phase samples n=3 separate LPG preparations for analysis.  
Parasite Growth 
Phase 
Average 
Repeats 
Parasite Growth 
Phase 
Average 
Repeats 
P-value 
LD4 Logarithmic 15 JABBA Logarithmic 30 <.0001 
Stationary 30 Stationary 47 
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Table 3.2: The ratio of mannose to glucose to galactose of cap samples based on 
capillary electrophoresis area calculations. The calculations were normalized to 
mannose. Note the decrease in galactose found in stationary JABBA LPG caps. Data was 
averaged from three separate runs of each sample.  
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Table 3.3. Cap isoforms and relative percentages found on JABBA LPG. Calculations 
were based on area percentages from capillary electrophoresis and permethylation 
experiments 
Oligosaccharide  Cap Structures Percentage of total 
sample
Disaccharides  Gal(β1,4)Man 50-80% 
Man(α1,2)Man 
 Glc(β1,2)Man 
Trisaccharides Gal(β1,4)[Man(α1,2)]Man 10-46% 
Gal(β1,4)[Glc(β1,2)]Man 
Tetrasaccharide Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man 0-4% 
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Table 3.4: Thin layer chromatography lipid migration distances. Distances were 
measured from the initial spot to the start of the final spot upon completion.  
Lipid Distance Migrated 
Phosphatidylinositol 9.5cm 
Phosphatidylcholine 10.5cm 
LD4 LPG Lipid 8.5cm 
Jabba LPG Lipid 8.5cm 
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Figure 3.1. Diagram of LPG from LD4 (wild-type) and JABBA LPG. The structure of 
the lipid anchor, is 1-O-alkyl-2-phosphatidylinositol. The percentages of the varying cap 
isoforms in JABBA are found in Table 3.3.  
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Figure 3.2. Representative SDS-PAGE of purified LPG from logarithmic phase and 
stationary phase wild-type LD4 and JABBA parasites.  Following electrophoresis the gel was 
stained with Stains-all solution. Each panel is from a different gel, but representative of the 
migratory differences. 
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Figure 3.3.  Fluorophore assisted carbohydrate electrophoresis of the 
dephosphorylated repeat units of LPG.  The band from JABBA co-migrating with the 
Gal(β1,4)Man disaccharide from wild-type LD4 repeat unit was determined to be 
identical based on β-galactosidase digestion and the linkage was confirmed by 
methylated alditol acetates by GC-MS.   
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Figure 3.4.  Monosaccharide capillary electrophoresis of dephosphorylated, strong 
acid treated repeat units from LD4 and JABBA. Mannose and galactose are found in 
equal proportions in both species, indicative of being found in equal percentage in both 
repeating units. Peaks at 11 and 13 min (unlabeled) are artifacts from the core and 
glucose. 
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Figure 3.5 Representative chromatogram from monosaccharide capillary 
electrophoresis for repeating unit quantification. The critical LPG derived peaks are 
labeled. Peaks at 11 and 13 min are a core associated artifact and exogenous glucose. 
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Figure 3.6. Fluorphore assisted carbohydrate electrophoresis of LD4 and JABBA 
caps collected from the logarithmic stage. LD4 has the standard monosaccharide, 
disaccharide, and trisaccharide , while JABBA has the presence of an additional 
trisaccharide and tetrasaccharide. The gel front is present just under the G1 marker in all 
3 lanes.  
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Figure 3.7 Oligosaccharide capillary electrophoresis of caps collected from 
logarithmic JABBA LPG. Disaccharides elute at 7 min, trisaccharides elute at 8 min, 
and tetrasaccharides elute at approximately 9 min. These bulk samples were treated with 
β-galactosidase, β-glucosidase, and α-mannosidase to determine their relative structures. 
Gal-Man, Man-Man, and Gal-(Man)Man elution times were similar in LD4. Injection 
pressure was 5 psi, 5sec to allow for better visualization of the tetrasaccharide.  
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Figure 3.8. Monosaccharide capillary electrophoresis of strong-acid hydrolyzed caps 
collected from logarithmic and stationary phase JABBA LPG. There is an absence of 
glucose in stationary phase JABBA LPG caps and wild-type LD4 (not shown), compared 
to logarithmic phase JABBA LPG caps. Ratios of each sugar are found in Table 3.2. 
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Figure 3.9.  GC-MS of partially methylated alditol acetates from a bulk sample of 
JABBA caps from LPG.  GC retention times were determined using Gal(β1,4)Man, 
Man, Gal, and Cellobiose standards. 2-Man and 2,4-Man were identified matching wild-
type GC retention times and MS spectra. T-Gal: terminal galactose, T-Man: terminal 
mannose, T-Glc: terminal glucose, 2-Man: 2-linked mannose, 4-Man: 4-linked mannose, 
2,4-Man: 2,4-linked mannose.  
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Chapter IV 
Characterization of the initiating mannosylphosphoryltransferase, the elongating 
mannosylphosphoryltransferase, and β-glucosyltransferase activities of JABBA and 
L. donovani 
1. Introduction
Many enzymes are responsible for the synthesis of LPG in the parasite. For the 
synthesis of the repeating units, an initiating mannosylphosphoryltransferase (iMPT) is 
required for addition of the mannose-phosphate (Man-P) to the core (Mengeling, B.J., et 
al. 1997b), a galactosyltransferase which adds the galactose to complete the first 
repeating unit (Carver, M.A. and Turco, S.J. 1991;Mengeling, B.J., et al. 1997a). An 
elongating mannosylphosphoryltransferase (eMPT) adds the next Man-P group, and the 
galactosyltransferase adds the next galactosyl unit to complete the second repeating unit 
(Descoteaux, A., et al. 1998).  
In some Leishmania species and strains, side chains are added to the repeating 
units at either the C-3 of the galactose or the C-2 of the mannose residues. L. donovani 
Sudanese isolates do not have any side chains on the repeating units, but do have an 
additional α-mannose on the C-2 of the cap’s mannosyl unit (Greis, K.D., et al. 
1992;Thomas, J.R., et al. 1992). L. donovani Indian isolate has a β-glucosyltransferase 
that adds β-glucose to the C-3 of the galactose, and it is subsequently downregulated as 
the parasite progresses from logarithmic to stationary phase (Mahoney, A.B., et al. 
1999;Mahoney, A.B. and Turco, S.J. 1999). Based on the structural changes in JABBA 
LPG, one would expect an increase in the eMPT activity and an increase in β-
glucosyltransferase activity. The iMPT, eMPT, and β-glucosyltransferase are explored 
here as potential causes for the modifications found on the LPG of JABBA, and are 
compared to both LD4 (Sudanese L. donovani, wild-type) and Mongi (Indian L. 
donovani) for a greater understanding of JABBA in the context of other L. donovani 
strains. 
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2. Results
The iMPT is required to add the first Man-P to the galactose of the core, with the rate
never expecting to vary, with the exception of the amastigote stage (Mengeling, B.J., et 
al. 1997b). Two hypotheses exist to the nature of the eMPT; either there are two that are 
stage specific or one that is regulated in an unknown manner (Routier, F.H., et al. 2000). 
L. donovani Indian isolate is used as a control for assaying the β-glucosyltransferase 
activity. The assays for both the iMPT and eMPT with product characterization are well 
documented (Carver, M.A. and Turco, S.J. 1992;Descoteaux, A., et al. 1998;Mengeling, 
B.J., et al. 1997b), so the only product characterization included here is that for the β-
glucosyltransferase. Schematics of reactions produced in each assay are found in Figure 
4.1 
A. Analysis of the iMPT and eMPT 
To account for the increased number of repeating units, there are two critical 
enzymes to consider that could cause this increase; the iMPT applying the first Man-P, 
and the eMPT applying every subsequent Man-P (Descoteaux, A., et al. 1998). Figure 4.2 
shows both iMPT and eMPT activity. The iMPT activity of LD4 (Sudanese L. donovani) 
had a rate of 250 pMol mannose-phosphate transferred and JABBA had a rate of 375 
pMol mannose-phosphate transferred per milligram protein/h; there was no statistical 
difference between the two. The activity of Mongi was no different from LD4 and 
JABBA. The eMPT activity was measured using JEDI LPG. LD4 (Sudanese  L. donovani 
) had 35 pMol mannose-phosphate transferred and JABBA had 70 pMol mannose-
phosphate transferred per milligram protein/h. The activity of the eMPT in Mongi had not 
previously been measured, and was shown to be very close to that of JABBA. Only 3  
counts had been taken, so no statistics were calculated using Mongi. While not shown 
here, the galactosyltransferase responsible for adding the galactose to the repeating units 
was initially surveyed, and no difference was observed.  
B. Analysis of the β-Glucosyltransferase 
The β-glucosyltransferase assay was adapted from the publication on L donovani 
Indian isolate (Mahoney, A.B. and Turco, S.J. 1999) and measures the last reaction found 
in Figure 4.1. JABBA showed an activity rate of 9 pMol glucose transferred per 
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milligram protein/h, compared to 4 for LD4 ( L. donovani Sudanese isolate) (Figure 4.3).  
The Mongi ( L. donovani India )control matched published data. The β-
glucosyltransferase is well characterized in Mongi ( L. donovani Indian isolate), but has 
never been analyzed in LD4 ( L. donovani Sudanese isolate) due to issues with the 
methodologies available at that time. To identify the origin of the β-glucosyltransferase in 
JABBA, it was critical determine if the apparent activity in vitro in LD4 ( Sudanese L. 
donovani)  was from the β-glucosyltransferase or was a strict artifact.  
C. Partial product characterization of the β-glucosyltransferase assay 
 Product characterization for the glucosyltransferase from L. donovani Sudan and 
JABBA was critical since there is no β-glucosyl chains on the LPG of the Sudanese 
isolate of L. donovani; it had been assumed that the activity from Sudanese L. donovani 
was an artifact (Mahoney, A.B. and Turco, S.J. 1999). Descending paper chromatography 
did not allow for product characterization, as the total radioactivity produced was 1/10th 
the amount required, so more sensitive methods were adapted.  If measuring β-
glucosyltransferase activity, a Gal-(Glc)Man or Glc-Gal-Man trisaccharide would be 
seen after mild acid hydrolysis alone or with dephosphorylation, if the activity was not 
present only a Gal-Man disaccharide would be evident. Capillary electrophoresis allowed 
for separation of any trisaccharide product present in the sample from the overwhelming 
amount of disaccharide repeating units. A number of conditions had to be met to 
determine if any present trisaccharide came from LPG. A trisaccharide was first found in 
both L. donovani and JABBA after mild acid hydrolysis and dephosphorylation using 
alkaline phosphatase. This suggested the trisaccharide was coming from the repeating 
units. Before continuing to analyze the trisaccharide, a number of conditions were tested 
that found the trisaccharide to be UDP-Glucose dependent, exogenous LPG dependent, 
and mild acid hydrolysis dependent (Data not shown). A small trisaccharide was found 
after mild acid treatment alone, suggesting the trisaccharide was also coming from the 
caps in addition to the repeats. From this it was concluded that the β-glucosyltransferase 
was acting on both the caps and repeating units in vitro in L. donovani and JABBA.  
While L. donovani having in vitro β-glucosyltransferase activity explains the 
presence of a β-glucose present on the cap of JABBA LPG, it was important to determine 
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if the galactosyl or the mannosyl unit was the acceptor for this β-glucose residue in 
Sudanese L. donovani. The trisaccharide was subjected to both β-galactosidase and β-
glucosidase treatment (Figure 4.4) and run on capillary electrophoresis for visualization 
to address this question. In both L. donovani and JABBA, the trisaccharide was sensitive 
to both treatments: β-glucosidase sensitivity indicates the trisaccharide is formed by the 
addition of a β-glucose, β-galactosidase sensitivity indicates a product of Gal-(Glc)Man 
instead of Glc-Gal-Man. This was expected in JABBA due to the mannose as the 
attachment point for the β-glucose in the caps, but unexpected in L. donovani Sudanese 
isolate due to the β-glucosyltransferase adding to the galactose in L. donovani Indian 
isolate.  
3. Discussion
The techniques to assay and solubilize LPG synthesizing enzymes have existed 
for years (Carver, M.A. and Turco, S.J. 1991;Carver, M.A. and Turco, S.J. 
1992;Descoteaux, A., et al. 1998;Mengeling, B.J., et al. 1997b)but two of the critical 
enzymes have only recently been identified. The LPG4 family consists of 3 enzymes, 
LPG4A, LPG4B, and LPG4C which have been identified as a proteophosphoglycan-
specific eMPT, the iMPT, and a LPG specific eMPT, respectively (Beverley et. al, 
unpublished observations). The eMPTs are related enough that functional rescue of both 
L. major knockouts of LPG4C, and the L. donovani mutant JEDI can be accomplished by 
complementation with LPG4A. With JABBA being a larger LPG mutant, it would be 
difficult to employ traditional techniques to identify the causal mutation.  
Regulation of these enzymes is poorly understood, though there is an 
understanding that a number of these enzymes are stage specific; particularly those for 
side-chains. The glucosyltransferase(s) in the Indian isolate of L. donovani (Mahoney, 
A.B. and Turco, S.J. 1999) responsible for the addition of β-glucose side chains show an 
80% decrease in activity in the progression from procyclic to metacyclic promastigotes. 
The arabinosyltransferase responsible for the capping of the side chains in L. major 
functions primarily in metacyclic phase . There are two hypotheses as to the nature of the 
regulation of eMPT activity, either one enzyme that is regulated differentially depending 
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on the stage, or two enzymes, one that functions during each phase (Routier, F.H., et al. 
2000). It has been proposed that a single eMPT should eventually be able to stop 
elongating, as it has less affinity for longer structures. The changes in JABBA suggest 
that not only is this not the case, there is a similar mode of regulation between the eMPT 
and the β-glucosyltransferase, as both are equally upregulated in comparison to wild-
type, but the iMPT is regulated in a different manner. 
 JABBA did have a slight increase in iMPT compared to LD4 and Mongi, which 
can be explained by the increase in eMPT activity. When LPG4A or LPG4C is knocked 
out, there is a significant decrease in iMPT activity (Beverley et. al, unpublished data). If 
these enzymes are working as a complex, or were to have a similar regulatory 
mechanism, the increase in eMPT activity could correlate with an increase in iMPT 
activity, even if there is less LPG on the cell.  
JABBA had twice the eMPT activity and β-glucosyltransferase activity of wild-
type LD4, in line with initial hypotheses. Surprisingly, Mongi eMPT activity more 
resembled that of JABBA than LD4. This would suggest that the eMPT and the β-
glucosyltransferase were regulated in the same fashion on some level: whether it be 
transcriptional or translational. One could potentially rule out regulatory factors as none 
required for activation in Mongi (L. donovani India) (Mahoney, A.B. and Turco, S.J. 
1999). As Leishmania genetic regulation is similar to that of bacteria (De Gaudenzi, J.G., 
et al. 2011), one would believe it is more likely due to post-translational regulation. 
The β-glucosyltransferase product characterization was critical to understanding 
the addition of the glucosyl residue to the caps in JABBA, and identifying potential 
mutations to cause this addition. While the product was partially characterized, it should 
be noted normal oligosaccharide CE has an injection rate of 0.4 psi for 4 sec, but for 
analysis of the trisaccharide 5 psi for 5 sec was required due to such low activity in LD4. 
The β-glucosyltransferase in LD4( L. donovani Sudan) and subsequently JABBA 
(Figure 4.1, bottom reaction) differs in acceptor specificity from the β-
glucosyltransferase in Mongi ( L. donovani India )(Figure 4.1, top reaction), but based on 
total cap data, appears to be stage-specific similar to the β-glucosyltransferase from 
Mongi  (L. donovani India). This suggests the two enzymes are related, and the change in 
acceptor is likely to be due to drift from the lack of in vivo use in LD4 (L. donovani 
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Sudan). As other L. donvani complex species such as L. infantum maintain a β-glucosyl 
residue linked to the galactosyl unit, it is unlikely for the shift to have changed from the 
mannosyl unit as the acceptor to the galactosyl unit, but through lack of use, the gene 
drifted. There is also a possibility another strain of L. donovani exists with a highly active 
β-glucosyltransferase attaching attaching a glucosyl residue to the mannosyl residue. 
There is a possibility that the β-glucosyltransferase only adds one glucose per 
1000 LPG molecules in LD4 in vivo, where it would never be seen from structural 
carbohydrate techniques, or acquisition of membranes actually results in activation. The 
only conclusive statement that can be made is that there is a β-glucosyltransferase in the 
genome of  LD4 (L. donovani Sudan) and is transcribed and translated into protein. Based 
on the nature of its position in JABBA, it is likely to have a greater preference for 
terminal repeating units and the increase in material created by the in vitro assay allowed 
for it to add a glucose to the mannose of repeating units.  
The base levels of the enzyme are low, and are most likely regulated at the 
transcriptional or translational level, while the increase in both the glucosyltransferase 
and the eMPT in JABBA suggests they are regulated in the same fashion. As Mongi (L. 
donovani India) has an increase in the eMPT activity compared to LD4 (L. donovani 
Sudan), one could hypothesize that the mutation in JABBA is activating a key regulatory 
difference between the two strains, leading to LPG that in structure and biosynthesis is 
more closely related to Mongi (L. donovani India) than the parent LD4 (L. donovani 
Sudan).  This could be a single regulatory difference, or changes at multiple regulatory 
points.  
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Figure 4.1. Schematic of the reactions measured in individual enzymatic assays 
comparing JABBA and LD4. The Gal(α1,6)Gal linkage in stachyose makes it an 
appropriate substrate for the iMPT activity(Mengeling, B.J., et al. 1997b). The β-GlcT 
assay was developed for Glc(β1,3)Gal linkage in the Indian isolate of L. 
donovani(Mahoney, A.B. and Turco, S.J. 1999), but also allows for measurement of the 
Glc(β1,2)Man linkage seen in JABBA LPG caps.  
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Figure. 4.2  Comparative iMPT and eMPT activities in microsomal preparations of 
wild-type LD4, JABBA, and Mongi. Microsomal preparations from wild-type LD4, 
JABBA, and Mongi  were assayed for iMPT and eMPT activities as described in 
Materials and Methods.  Top Panel, iMPT activity, N=3; Bottom Panel, eMPT 
activity.N=8 microsomal preparations with the exception of Mongi, N= 3.  Error bars 
represent standard deviation.  
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Figure. 4.3  Comparative β-glucosyltransferase activities in microsomal 
preparations of wild-type LD4 , JABBA, and Mongi.  Microsomal preparations from 
wild-type LD4, JABBA, and Mongi were assayed for β-glucosyltransferase activities as 
described in Materials and Methods.  N= 8 microsomal preparations for LD4 and 
JABBA, 3 for Mongi. Statistics were not calculated for Mongi. Error bars represent 
standard deviation.  
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Figure 4.4. Partial characterization of the product produced by JABBA β-
glucosyltransferase assays using whole LPG. Disaccharides run at 7 minutes elution 
time; trisaccharides run at 8 minutes. Top Panel: Mild Acid Hydrolyzed, 
dephosphorylated product.  * Gal-(Glc)Man, **Gal-Man. Middle Panel: β-glucosidase 
treated after mild acid hydrolysis and dephosphorylation. ** Gal-Man. Lower Panel: β-
galactosidase treated after mild acid hydrolysis and dephosphorylation. *** Glc-Man. 
LD4 profiles (not shown) look the same. 
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Chapter V 
Determining the cause of Ricin Resistance 
 
1. Introduction 
 Ricin, specifically RCA120, has been used to identify LPG-null Leishmania 
mutants (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;King, D.L. and Turco, 
S.J. 1988;Ma, D., et al. 1997) for the identification of critical LPG biosynthesis pathways 
and genes. Prior to JABBA, the mutants presented were all LPG null, expressing 
truncated LPG that often did not terminate in a galactose molecule. As RCA 120 is highly 
reactive with terminal β-galactosyl units, more so than other terminal β-galactosyl 
binding lectins like peanut agglutinin, these truncated LPG structures clearly explain the 
cause of ricin-resistance (Andrade, A.F. and Saraiva, E.M. 1999). JABBA is the first 
mutant with large LPG published to date, leaving the resistance to ricin a mystery.  
 There are two options to explain ricin resistance in JABBA parasites, either the 
unique cap structures containing a β-glucosyl residue could block the ability for ricin to 
bind to the LPG even if a galactose is present, or the number of repeating units blocks 
access to the caps, causing the caps to become “cryptic”.  The “cryptic caps” hypothesis 
is supported by both nuclear magnetic resonance imaging showing LPG to have a helical 
structure and from assays showing that metacyclogenesis and the elongation of LPG 
blocks access of lectins to the caps (Homans, S.W., et al. 1992;Sacks, D.L., et al. 1995) 
allowing for release from the sand-fly gut. These two hypotheses are modeled in Figure 
5.1.  Understanding why JABBA is ricin-resistant will help to explain the critical events 
required for release of the parasite from the sand-fly gut to continue its life-cycle.  
2. Results 
 Peanut Agglutinin (PNA), Concanavalin A (ConA), and Ricin (RCA 120) are 
considered to have equal abilities to agglutinate logarithmic parasites when used at 
appropriate concentrations (Andrade, A.F. and Saraiva, E.M. 1999). Selection was 
originally performed with multiple rounds of ricin at 100 µg/ml (King, D.L. and Turco, 
S.J. 1988). As mentioned previously, L. donovani produces roughly 100 pMol of LPG / 
107 parasites, while JABBA produces only 30.  
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A. Lectin Resistance 
Traditionally, lectins have been used to determine if the LPG cap is accessible 
(Sacks, D.L., et al. 1995). Logarithmic L. donovani has been shown to be agglutinated by 
both ConA, being able to bind the Man(α1,2)Man found on the terminus of some caps, 
and PNA which recognizes the terminal galactose found on a number of caps. ConA, 
PNA, and RCA 120 were all tested. Previously published data shows approximately 10 
µg of ricin, or 100 µg of ConA or PNA, is sufficient to agglutinate L. donovani (Andrade, 
A.F. and Saraiva, E.M. 1999). The previously mentioned critical density designations for 
logarithmic and stationary phase were maintained throughout the entire experiment. 
When exposed to 100 µg/ml of ConA, 7% of logarithmic phase L. donovani 
parasites and 25% of logarithmic phase JABBA parasites showed resistance. In stationary 
phase, 14% of L. donovani and 30.73% of JABBA parasites were resistant to ConA 
(Figure 5.2, top panel). The L. donovani resistant percentages are similar to those 
published (Sacks, D.L., et al. 1995). The difference between L. donovani and JABBA in 
both logarithmic and stationary phases was found to be significant, but the difference 
between logarithmic and stationary phases of JABBA was not.  
 After treatment with 100 µg/ml of PNA only 1% of logarithmic and 6.27% of 
stationary L. donovani parasites showed resistance, similar to published data. Of treated 
JABBA parasites, 8.5% showed resistance in logarithmic phase, and 16% showed 
resistance in stationary phase (Figure 5.2, bottom panel). The difference in resistance 
values between L. donovani and JABBA in both logarithmic and stationary phases was 
found to be significant, as was the difference between logarithmic and stationary JABBA. 
Additionally, both L. donovani and JABBA parasites were grown in the presence of 100 
µg/ml of PNA and the LPG was extracted. The total amount of LPG extracted from both 
parasites doubled, showing selection with PNA in both parasites increases the total 
apparent amount of surface LPG.  
Selection experiments were repeated with 10 µg/ml RCA 120, which is 
considered to have similar agglutination properties as PNA at 100 µg/ml concentration. 
Approximately 2.4% of logarithmic L. donovani parasites showed ricin resistance, as did 
about 3.5% of stationary L. donovani.  Approximately 7.05% of logarithmic JABBA 
parasites showed ricin resistance, as did 15.5% of stationary JABBA parasites (Figure 
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5.3). A significant difference between L. donovani and JABBA was found in both phases, 
as well as between logarithmic and stationary JABBA with a <0.005 p-value. 
B. Galactose Oxidase Accessibility 
In previous publications, the accessibility of terminal galactose to the caps of LPG 
on whole cells to galactose oxidase has been critical in making the observation on the 
accessibility of the caps to molecules (Sacks, D.L., et al. 1995). Unfortunately, measuring 
this required reduction with tritiated sodium borohydride, and the reaction’s byproduct: 
tritiated hydrogen gas. We attempted to make use of the sensitivity of capillary 
electrophoresis to avoid use of tritiated sodium borohydride. By comparing the reduction 
of total galactose in caps treated with galactose oxidase and comparing it to caps from 
untreated parasites, one could calculate the relative amount of galactose available to 
galactose oxidase. Greater than 85% of galactose on logarithmic phase L. donovani is 
accessible to galactose oxidase, while only 35% is available on stationary phase parasites. 
This 3-fold change is similar to the change in radioactivity between L. donovani 
logarithmic phase and stationary phase in previously published data.  In logarithmic 
phase JABBA had approximately 31% terminal galactose to galactose oxidase, in 
stationary phase only 8% of its terminal galactose was accessible (Table 5.1). 
 
3. Discussion 
Previously, ricin-resistance mutants were characterized if they were defective in LPG 
synthesis.  To date the four mutants characterized have been R2D2, C3PO, OB1, and 
JEDI (Descoteaux, A., et al. 2002;Descoteaux, A., et al. 1998;King, D.L. and Turco, S.J. 
1988;Ma, D., et al. 1997)The LPG of two of these mutants did not possess a terminal 
galactose, and only JEDI’s LPG contained a full repeating unit. Despite possessing a 
terminal galactose, JEDI demonstrated ricin-resistance, leaving the exact mechanisms of 
ricin selection unknown. Of the entire set of recovered mutants, two were over-
expressing mutants: JABBA and HUTT. HUTT was abandoned due to abnormally low 
levels of LPG synthesis. JABBA is the first large LPG mutant characterized, allowing for 
the investigation of its specific mechanism of ricin resistance. 
The most significant lectin data was found using peanut agglutinin and ricin, both of 
which recognize terminal galactose. In both cases, there is a significant difference in 
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resistance between L. donovani and JABBA at both logarithmic and stationary phases, 
but also between the logarithmic and stationary JABBA parasites. These differences 
suggest that the number of repeating units was the greatest influence on ricin resistance. 
Previous data has shown that LPG is helical in nature (Homans, S.W., et al. 1992), and 
that the only major LPG structural change in L. donovani from procyclic phase to 
metacyclic phase is the number of repeating units. This change in LPG length is 
potentially responsible for the cap becoming “cryptic” or otherwise inaccessible to lectins 
(Sacks, D.L., et al. 1995). This is further supported by the stark increase in resistance of 
JABBA from logarithmic to stationary phases. The presence of a significant difference in 
resistance between JABBA logarithmic and L. donovani stationary parasites suggests that 
the addition of glucose to the caps confers some additional resistance to terminal 
galactose binding lectins. 
While only 10 µg/ml of ricin was used compared to the original selection levels of 
100 µg/ml, the densities for mutagenesis suggest the parasites were selected using what 
we now define as stationary parasites. Original work states that parasites were selected 
when grown to densities of 2.0 x 106 to 2.0 x 107 parasites/mL (Iovannisci, D.M. and 
Ullman, B. 1984;King, D.L. and Turco, S.J. 1988), and JABBA shows the repeating unit 
increase and loss of cap glucosyl residues starting at 3.0 x 106 parasites/mL. As originally 
selected the parasites had an average repeating unit length of 42, substantially higher than 
the logarithmic phase repeating unit length of 30. 
ConA most often recognizes Man(α1,2)Man, a structure found in L. donovani caps. 
The Man(α1,2)Man cap is not as dominant an isoform in JABBA cap structures 
compared to its prominence in L. donovani, thus explaining JABBA’s phase independent 
resistance to ConA.  
Total LPG collected nearly doubled in both L. donovani and JABBA when exposed to 
peanut agglutinin. L. donovani binds to the insect gut via galectins: lectins that recognize 
galactose (Kamhawi, S., et al. 2004). If that is the case, selection via terminal galactose 
lectins during stationary phase would identify parasites which successfully release from 
the insect gut. An increase in the number of molecules of LPG on the cell surface would 
only be relevant to the survival of the parasite once it has entered the mammalian 
bloodstream (Franke, E.D., et al. 1985;Green, P.J., et al. 1994). LPG protects against 
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complementation and other factors that would cause inevitable parasite death if they 
reached the cell surface.  
Using galactose oxidase, the relative percentage of surface galactose accessible can 
be calculated in order to determine just how cryptic the cap is. Capillary electrophoresis 
was used in lieu of radioactivity. In theory, capillary electrophoresis could have 
quantified total moles of product, but this proved difficult as the galacto-hexodialdose 
product does not necessarily label as a single peak; the labeling scheme for capillary 
electrophoresis relies the monosaccharides having only one reducing end, it has two. Due 
to this fact, direct analysis of the dialdose product was not possible, so the quantification 
of accessible galactose was done against untreated caps and normalizing to the total 
amount of mannose in the sample. This did not appear to affect the data for LD4 
(Sudanese L. donovani), but decrease in galactose in stationary JABBA caps could’ve 
helped skew the data.  
Two hypotheses can be made to put all of the ricin and other lectin resistance data in 
perspective in regards to the life cycle of the parasite. At 15 repeating unit LPG, the 
procyclic promastigote binds to lectins in the sand fly gut, we can surmise from the 
resistance data the parasite has the best chance of survival with a greater number of LPG 
molecules on the cell surface and with greater than 30 repeating units on LPG molecules. 
It remains unclear exactly why parasites resistant to PNA have an apparent increased 
amount of LPG on the cell surface, but one possibility is that parasites with fewer 
molecules agglutinate as the lectins reach the layers of the glycocalyx closer to the cell 
surface and binding to terminating galactosyl residues present.  These differences could 
be investigated using LPG collected from parasites using the ability for red blood cells to 
be opsonized, or how parasites survive complement if they’ve been exposed to PNA.  
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Table 5.1. The percentage galactose available to galactose oxidase based on capillary 
electrophoresis quantification. Averages were determined using seven experiments 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parasite Growth Stage Galactosyl Residues 
oxidized (%)  
LD4 Logarithmic >85 
 Stationary   35 
JABBA Logarithmic   31 
 Stationary    8   
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B. 
 
 
 
 
 
 
 
Figure 5.1: Two potential models for ricin-resistance of JABBA parasites. A. This 
model relies on the use of abnormal cap structures in logarithmic phase to block binding 
of ricin to terminal β-galactose. B. The entire cap becomes inaccessible due to curvature 
of the LPG due to the number of repeats. This model could result in increased binding in 
logarithmic or stationary phase parasites.  
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Figure 5.2: Agglutination profiles of logarithmic and stationary parasites exposed to 
Concanavalin A and Peanut Agglutinin. Top panel: Logarithmic and stationary 
parasites of both LD4 and JABBA were exposed to Concanavalin A for 30 minutes, and 
the free cells were counted. The p-values between parasites in the same phase are <.01. 
Bottom panel: Logarithmic and stationary parasites were exposed to Peanut Agglutinin 
for 30 minutes and free cells were counted. The p-values between parasites in the same 
phase were <.01. . Minimum of 4 separate counts was used for each average. Error bars 
are representative of standard deviation.  
 
 
p-Value <.01 
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Figure 5.3: Agglutination profiles of logarithmic and stationary parasites exposed to 
Ricin. Parasites grown in logarithmic and stationary phase were exposed to ricin (RCA-
120) at 10 µg/ml concentration for 30 min. Free cells were counted. The p-value 
comparing parasites of the same phase was <.005. Averages were a minimum of 4 
separate runs.  Error bars are representative of standard deviation. Stationary phase 
JABBA was most likely the structure found on the parasites originally selected after 
mutagenesis.  
 
 
p-Value <.0001 
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Chapter VI 
Conclusions and Future Directions 
 
 The creation of lpg- mutants in our lab using mutagenesis with N-methyl-N’-
nitroso-N-nitroguanidine and selection by ricin agglutinin has resulted in the direct 
identification of the genes LPG1, LPG2, LPG3, and LPG4A (Descoteaux, A., et al. 
2002;Descoteaux, A., et al. 1998;Hong, K., et al. 2000;King, D.L. and Turco, S.J. 
1988;Ma, D., et al. 1997;Ryan, K.A., et al. 1993b) and aided in the identification of 
LPG4B and LPG4C. LPG4A has a primary function in the elongation of glycan chains on 
proteophosphoglycans, while the other five genes are directly involved in the synthesis of 
LPG. While selection with ricin agglutinin was designed to identify parasites with 
truncated LPG; the identification of hyper-phosphoglycosylated mutants from this project 
was completely unexpected. The goals of this project were to determine the structure of 
JABBA’s LPG, determine the cause of its ricin resistance, and identify any changes in 
glycosyltransferases involved in LPG biosynthesis.  
 JABBA has a unique larger LPG structure; in all phases, JABBA LPG has a 
higher molecular weight than wild-type. The repeating unit structure is the same as wild-
type, being identified as 6Gal(β1,4)Man(α1)PO4 (Figures 3.3 and 3.4), but JABBA LPG 
has an increase in the number of repeating units compared to wild-type. Logarithmic 
phase JABBA LPG has 30 repeating units, stationary phase LPG has 47, in comparison to 
wild-type’s 15 repeating units in logarithmic phase and 30 in stationary phase (Table 
3.1). Logarithmic phase JABBA starts as “metacyclic length” LPG and continues to 
increase in size as it would during a normal life cycle.  
 JABBA LPG also differs in its cap isoforms. JABBA has a total of six cap 
isoforms, the three dominant isoforms found in wild-type and three containing a 
Glc(β1,2)Man linkage (Table 3.3). The unique isoforms are Glc(β1,2)Man , 
Gal(β1,4)[Glc(β1,2)]Man, and Gal(β1,4)[Glc(β1,2)Man(α1,2)]Man. The Glc(β1,2)Man 
linkage is not found in any other parasite. The β-glucose is stage specific, and the 
glucose-containing cap isoforms are downregulated as the parasite progresses from 
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logarithmic to stationary phase, starting at a relative density in culture of 3.0 x 106 
parasites/ml (Figure 3.8).  
 Differences in the eMPT and β-glucosyltransferase activity are responsible for the 
structural differences in JABBA LPG (Figures 4.1 and 4.2), as the activity of both of 
these enzymes in JABBA is double that in wild-type. No statistically significant 
difference in the iMPT activity of JABBA and wild-type was found, but a slight increase 
in mean activity is evident.  Analyzing the product of LD4 (wild-type Sudanese L. 
donovani) β-glucosyltransferase assay helped explain how a mutagenized parasite from a 
species that does not have an in vivo active β-glucosyltransferase seemingly had an active 
one. 
The β-glucosyltransferase product from LD4 (wild-type Sudanese L. donovani 
)and JABBA characterized as a βGal-(βGlc)-Man trisaccharide, similar to the 
trisaccharide found on JABBA caps. This activity in both the parent and JABBA differed 
from Mongi (L. donovani Indian isolate) that has a β-glucosyltransferase which adds to 
the galactose of repeating units and cap, and explains that the enzyme, which only active 
in vitro in the wild-type, when upregulated would explain the unique cap structures.  
Results of agglutination with peanut agglutinin, ricin agglutinin, and concanavalin 
A, along with the reduced accessibility of terminal galactose to galactose oxidase, 
suggests that the primary mechanism for resistance comes from the number of repeating 
units causing the caps to become cryptic, not the unique cap structures. Stationary 
parasites, which do not contain the unique cap isoforms, showed the greatest resistance to 
agglutination by lectins and the least accessibility of terminal galactose to galactose 
oxidase. The structure of the LPG found at this density was most likely selected after 
mutagenesis based on the densities the parasites at which ricin selection occurred.  
The initial structural and biosynthetic analysis of JABBA LPG allows for a few 
important conclusions to be drawn. The significant increase in unagglutinated parasites 
after exposure to ricin or peanut agglutinin, along with a decrease in the amount of 
galactose available to galactose oxidase between logarithmic and stationary phase 
JABBA parasites, shows that every repeating unit over 30 increases the likelihood that 
the cap is going to become “cryptic” and inaccessible to lectins. Those parasites resistant 
to lectins have an increased amount of LPG collected from the cell surface, even in wild-
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type, while the structure of LPG is not overtly changed. The cause is unknown, but a 
denser glycocalyx would provide greater protection as the parasite attempts to infect a 
mammalian host. Lastly, LD4( wild-type L. donovani Sudanese isolate) contains a β-
glucosyltransferase active in vivo that is regulated at some point post-translationally to 
inhibit its activities. This β-glucosyltransferase differs from Mongi (Indian isolate), as it 
uses mannose as the acceptor instead of galactose.  
Further studies of JABBA are complicated compared to the original lpg- mutants 
as up regulation of enzymes does not allow for identification of the mutation in JABBA 
parasites using the traditional cosmid approach. A diagram of the ways JABBA can be 
studied is found in Figure 6.1. To rule out any transcriptional up-regulation in JABBA, 
quantitative PCR could be used to look at transcript levels of LPG4C, the eMPT. This 
may not be conclusive due to the polycistronic transcripts produced by Leishmania 
parasites. The best mechanism to further study JABBA would be to identify the putative 
β-glucosyltransferase from the L. donovani genome, and trace the difference from each 
strain and identify the differences. Putative β-glucosyltransferases could also be 
identified using bioinformatics data from other trypanosomes.  
 The other, simpler, question to tackle is if it is truly an upregulation resulting in 
an increased amount of enzyme found in JABBA, or if it is point mutations found in the 
eMPT. Data from the LPG4A, LPG4B, LPG4C project could allow for sequencing of 
LPG4C from JABBA to eliminate the possibility of a point mutation in LPG4C affecting 
the rate. Antibodies from LPG4A created from previous work could potentially be used 
to total the amount of all three enzymes and compare, but will not elucidate the two 
eMPTs and the iMPT. Little work has been done on the genetic regulation of Leishmania 
parasites, particularly involving metacyclogenesis, but JABBA has the potential to 
increase understanding.  
JABBA provides a unique method for identifying how certain changes affect the 
parasite throughout its life cycle. JABBA parasites should be studied with both the 
logarithmic and stationary phases in the sand fly and mouse models of infectivity. In the 
sand fly, it should be identified if the parasite can bind at all to the sand fly gut and, if so, 
does the glucose containing cap structure affect binding. We saw some minor, but not 
significant evidence it had an effect on lectin binding, as in many cases the logarithmic 
77 
 
JABBA parasites were more resistant to lectins than stationary L. donovani parasites. 
Stationary phase parasites should also be checked for their ability to bind to the sand fly 
gut, but based on the lack of galactose oxidase sensitivity one would find it unlikely.  
In the mouse model of infectivity, the required parasite burden to produce an 
infection should be measured in both logarithmic and stationary phase, with the overall 
immune response compared to that of normal metacyclic parasites. There is a distinct 
possibility in both phases that there is a stronger or altered immune response as either the 
glucose present in logarithmic phase caps or the increase in repeating units could change 
the innate immune response. Current data have shown the responses from TLR2 and 
TLR4 could vary based on these changes (Ibraim, I.C., et al. 2013). With these studies on 
infectivity and the immune response, the ability to trigger the complement cascade along 
with the response of other blood serum factors should be examined as it could be 
comparatively altered. JABBA provides a unique view that we have not had for studying 
the parasite and its life cycle, since many hypo-phosphoglycosylated LPG mutants exist 
but JABBA is the first hyper-phosphoglycosylated LPG mutant.  
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Figure 6.1: Flow-chart of ways to pursue future study of JABBA.  
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